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Avian influenza virus has a segmented RNA genome that allows the virus to 
evolve continuously and generate new strains.  Wild birds serve as natural reservoirs of 
avian influenza virus and provide a potential source for emergence of new viruses, which 
traverse host barriers and infect new avian or mammalian species.  The mechanisms 
involved in this process are not completely understood.  Our main goal is to understand 
host-pathogen interactions involved in avian influenza pathogenicity.  As part of our 
approach we studied the effect of pre-exposure of chickens to IBDV (infectious bursal 
disease virus) on host susceptibility to infection, disease progression, and host molecular 
responses to infection with a mallard H5N2 low pathogenic avian influenza (LPAI) virus. 
 
We found that prior exposure of chickens to IBDV led to increased susceptibility 
to infection with the mallard H5N2 LPAI virus compared to normal chickens. This 
  
increased susceptibility allowed us to further adapt the virus to chickens.  After 22 
passages (P22) in IBDV-pre-exposed chickens, the LPAI virus replicated substantially 
better than the wild-type (WT) mallard virus in both IBDV-exposed and normal chickens. 
Interestingly, the P22 virus showed similar levels of replication in the respiratory and 
intestinal tracts of both groups, although it caused exacerbated signs of disease and severe 
lesions in the IBDV-pre-exposed group.  We suggest that prior IBDV exposure provides 
a port of entry for avian influenza in an otherwise resistant chicken population.  
Furthermore, adaptation of avian influenza (AI) in IBDV-exposed chickens may allow 
for the selection of AI virus strains with expanded tissue tropism.  We also studied the 
effects of host response to H5N2 AI in normal and IBDV-infected birds using high-
throughput gene expression analysis.  We demonstrated that IBDV-exposed chickens 
showed less than optimal humoral responses to LPAI infection as well as alterations in 
local molecular pathways that eventually led to exacerbated disease and death.  At the 
molecular level we found amino acid substitutions in the surface glycoprotein 
hemagglutinin (HA).  Those changes suggest selection for a virus that binds to and 
replicates more efficiently in chickens.  Taken together our results suggest that IBDV-
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Chapter 1: General Introduction 
 
1.1Introduction 
The influenza A virus is a single-stranded, negative-sense segmented RNA 
virus that belongs to the family Orthomyxoviridae.  Influenza A is comprised of 
eight genes, which encode at least eleven different proteins (Horimoto and Kawaoka, 
2005; Steinhauer and Skehel, 2002; Subbarao and Joseph, 2007).  The gene segments 
are encapsidated by a virally encoded nucleoprotein (NP) and the ribonucleoprotein 
(RNP) structures are associated with the three subunits of the viral polymerase: 
polymerase basic 1 (PB1), polymerase basic 2 (PB2) and polymerase acid (PA) 
(Steinhauer and Skehel, 2002).  Two surface proteins, hemagglutinin (HA) and 
neuraminidase (NA) are the main antigenic determinants of the virus to which 
neutralizing antibodies are made.  A significant characteristic of the influenza virus, 
which makes it such an important threat, is its potential for variability.  The virus can 
change gradually due to the accumulation of point mutations in the process known as 
antigenic drift.   It is generally accepted that immunological pressure favors antigenic 
drift to a higher extent in humans but this phenomenon also occurs in avian influenza 
virus (Horimoto and Kawaoka, 2001).  In addition, the segmented nature of the 
genome increases the opportunity for genetic reassortment; this leads to generation 
of different strains (Webster et al., 1997, Shortridge et al. 1997) in a process known 
as antigenic shift, which is a key factor in the emergence of pandemic strains.  




surface proteins HA and NA.  Currently 16 hemagglutinin (H1-16) and 9 
neuraminidase (N1-9) subtypes (Fouchier et al., 2005; Munster et al. 2005, Horimoto 
and Kawaoka, 2005) have been described. The primary host reservoir for all avian 
influenza viruses is wild aquatic birds (Munster et al., 2005; Perdue and Swayne, 
2005; Webster et al., 1992).  It has been shown that adaptation of avian influenza 
virus isolated from aquatic birds to chickens is the result of selective pressure, which 
leads to marked changes in both the HA and NA genes (Matrosovich et al., 1999).  
Type A influenza viruses are the agents of the most common and endemic infections 
and have been reported in swine, horses, wild birds – particularly the families 
Anseriforme (ducks, geese and swans) and Charadriiforme (shorebirds), domestic 
poultry, and humans (Fouchier et al., 2005; Horimoto and Kawaoka, 2005; Humberd 
et al., 2006).  Sporadic infections have been reported in farmed mink, dogs, wild 
whales and seals, and captive populations of big cats (tigers and leopards) (Perdue 
and Swayne, 2005; Rimmelzwaan et al., 2006).  
 
Avian influenza viruses can be separated into two major classes on the basis 
of virulence.  The highly pathogenic avian influenza (HPAI) viruses cause severe 
systemic infection with birds dying soon (usually within one week) after infection and 
are associated with high rates of morbidity and mortality. The low pathogenic avian 
influenza (LPAI) viruses are associated with subclinical infections and produce only 
mild to moderate signs of disease in the field (Horimoto and Kawaoka, 2005).  Only 
influenza viruses of subtypes H5 and H7 are categorized as HPAI viruses (Swayne 




frequently involved in outbreaks of HPAI virus-related disease.  Although there is no 
recognized wild-bird reservoir, HPAI viruses can be isolated from wild birds during 
outbreaks in domestic poultry (Swayne and Suarez, 2000).  Phylogenetic analysis 
indicates that pathogenic viruses of the H5 and H7 subtypes may be derived from 
nonpathogenic lineages that are maintained in aquatic birds (Kawaoka et al., 1987; 
Rohm et al., 1995). 
 
Influenza A virus pathogenicity is complex and of a polygenic nature 
(Steinhauer and Skehel, 2002)  however, the glycoprotein HA  is integral to the 
process (Horimoto and Kawaoka, 2005; Kuiken et al., 2006).  Cleavage of HA into 
the subunits HA1 and HA2 (Lazarowitz and Choppin, 1975) is considered to be the 
main determinant of  tissue tropism of avian influenza viruses.  Differences in the 
tissue distribution of proteases and in HA susceptibility to these enzymes can 
determine the severity of virus infection (Horimoto and Kawaoka, 2005) and define 
the range of tissues where viral replication can occur.  For certain avian strains of 
subtypes H5 and H7, the cleavage properties of HA are the most significant 
determinant of virus pathogenicity.  The HAs of these viruses contain a series of basic 
amino acids (Kawaoka and Webster, 1988b; Wood et al., 1993), which are cleaved in 
the Golgi apparatus by ubiquitous intracellular proteases; the ubiquity of these 
proteases, such as furin or PC6 (Horimoto et al., 1994; Stieneke-Grober et al., 1992), 
facilitates the systemic spread of the virus (Steinhauer and Skehel, 2002).  Conversion 
of avirulent avian influenza viruses to virulent strains has been associated with an 




in 1983 (Kawaoka et al., 1984), in Mexico (H5N2) in 1994 (Garcia et al., 1996; 
Horimoto et al., 1995),  in Italy (H7N1) in 1997 (Banks et al., 2001), in Chile (H7N3) 
in 2002 (Suarez et al., 2004), and in Canada (H7N3) in 2004 (Hirst et al., 2004).  In 
nonpathogenic viruses HA generally contains a single basic amino acid at the 
cleavage site; this basic amino acid is readily recognized and cleaved by extracellular 
trypsin-like proteases, limiting the effects of the virus to mild respiratory symptoms 
and a reduction in egg production (Bosch et al., 1979; Stieneke-Grober et al., 1992).  
The presence or absence of carbohydrate attachment sites adjacent to the cleavage 
loop can also affect HA cleavage properties.  There are examples in which mutations 
that eliminate such glycosylation sites led to acquisition of a highly pathogenic 
phenotype (Deshpande et al., 1987; Kawaoka et al., 1984; Kawaoka and Webster, 
1989). 
 
Despite the availability of these data describing molecular events associated 
with pathogenicity, the mechanism(s) by which an avirulent avian virus becomes 
highly virulent in nature is poorly understood.   However, the transition to 
pathogenicity should be considered a polygenic event, in which several gene 
segments can contribute to the pathogenic phenotype; this process depends on factors 
such as the genetic characteristics of the virus, the nature of the host, and the route of 
infection (Steinhauer and Skehel, 2002). 
 
A very interesting area of research involves the role that host factors may play 




avian influenza viruses in avian species are unknown (Horimoto and Kawaoka, 
2005).  Although avian influenza viruses typically demonstrate host specificity, 
interspecies transmission occasionally occurs (Perkins and Swayne, 2001).  
Following transmission, the influenza A virus must go through a process of 
adaptation to the new host species before efficient replication can be achieved.  
Replication efficiency is associated with expression of virulence (Perkins and 
Swayne, 2003); however, the factors that determine interspecies transmission and 
pathogenicity of influenza viruses remain poorly understood. 
 
Many parameters of the role of host factors in determining differences in 
degree of virulence of influenza viruses are related to the immune response.  
Increased susceptibility to infection, as a result of genetic variation in viral receptors 
or other properties of host cells, might allow more rapid spread within tissues (Perdue 
and Swayne, 2005).  Elucidation of the mechanisms by which influenza virus adapts  
in poultry, a non-natural host of avian viruses, is crucial for determining how the 
virus might potentially improve its transmissibility among humans (Campitelli et al., 
2006).  
 
Although other factors are involved, the genetically-determined diversity of 
the immune system is the major factor underlying differences between individuals in 
resistance to diseases of infectious origin.   Infectious disease occurs when the 
immune system fails to protect the organism, due to an inadequate or abnormal 




can be correlated with resistance or susceptibility to a pathogen (Zekarias et al., 
2002).  In this regard, infections caused by infectious bursal disease virus (IBDV) 
may exacerbate the outcome of diseases caused by other etiologic infectious agents, 
such as viruses and bacteria, and reduce the chicken’s ability to respond to 
vaccination (Muller et al., 2003).  Previous studies have shown that IBDV-induced 
immunosuppression causes a reduced post-vaccination immune response and greater 
susceptibility to challenge in viral respiratory diseases, such as Newcastle disease, 
avian infectious bronchitis, and avian infectious laryngotracheitis in chickens 
(Rosenberger and Gelb, 1978).  Because host immune competence is a factor in 
determining predisposition to infectious agents and IBDV-induced 
immunosuppression increases susceptibility to viral respiratory infections (Muller et 
al., 2003), it is essential to determine the precise effects that pre-exposure to IBDV 
has on the host and how IBDV pre-exposure influences subsequent infection by avian 
influenza viruses in poultry (Fouchier et al., 2005). 
 
IBDV is one of the major, economically important diseases of poultry globally 
(Sharma et al., 2000) due to its detrimental effect on the immune status of the host.  
Both broiler and layer flocks are vulnerable to the immunosuppressive effects of the 
virus (Saif, 1991).  It is generally accepted that both humoral and cellular immune 
responses are compromised (Rosenberger and Gelb, 1978).  The degree of 
immunosuppression depends on several factors but the age at which poultry are 
infected plays an important part, with greater impairment in younger chicks, infected 




1991).  This is an important consideration because commercial chickens are typically 
exposed to IBDV early in life (Saif, 1991), giving other pathogens the opportunity to 
take advantage of a debilitated immune system.  
 
1.2 Research Objectives 
Determination of the susceptibility of chickens to A/mallard/12180/ 
Pennsylvania/84 (H5N2) influenza A virus using natural routes of inoculation. 
 
Adaptation of A/mallard/12180 /Pennsylvania/84 (H5N2) influenza A virus in 
chickens that have been pre-exposed to IBDV.  By successively passing the influenza 
virus in IBDV-infected chickens we expect to obtain new variants of the virus, which 
will adapt, replicate, and transmit more efficiently in birds/domestic poultry.  This 
process will provide the basis for establishing the role of host immune status in the 
susceptibility of chickens to AIV.  
 
Study the pathogenesis of the A/mallard/Pennsylvania/84 (H5N2) avian 
influenza virus after adaptation in chickens pre-exposed to IBDV.  This study will 
provide data on changes in tissue tropism and/or pathogenicity after passing the 





Molecular characterization of wild-type and adapted viruses. Sequence analysis 
of the adapted and non-adapted viruses will provide data necessary to define the 
mutational variations that lead to the adapted phenotype. 
 
Determination of global gene expression profile using microarray 
analysis.  Analysis of the patterns of global gene expression of normal and IBDV-
pre-exposed chickens inoculated with the adapted avian influenza virus will provide 








Chapter 2: Review of Literature 
 
 
2.1 Influenza Virus 
2.1.1 Classification 
Influenza virus belongs to the family Orthomyxoviridae and to the genus 
Influenza virus A.  The genome of influenza virus is single stranded, negative-sense, 
segmented RNA (Subbarao and Joseph, 2007).  Viruses in the genus Influenza are 
recognized for their ability to undergo genetic reassortment (Knipe, 2007).  
 
Influenza A viruses are further classified according to their hemagglutinin 
(HA) and neuraminidase (NA) subtypes.  Sixteen hemagglutinin (H1 to H16) and 
nine neuraminidase (N1 to N9) subtypes of influenza A viruses have been described 
(Halvorson, 2008; Knipe, 2007; Landolt and Olsen, 2007). 
 
2.1.2 Virion 
Influenza virus is pleomorphic and enclosed by a lipid envelope derived from 
the host cell.  HA and NA project in a spike-like fashion from the surface of the 
virion and are anchored in the lipid membrane.  The M1 protein is located within the 
envelope and the M2 protein within the envelope acts as an ion channel. The core of 
the virus particle contains the RNP (ribonucleoprotein) complex, which consists of 




PB2 (polymerase basic 2) and PA (polymerase acid), and the nucleoprotein (NP) 
(Knipe, 2007; Landolt and Olsen, 2007). 
 
2.1.3 Genome Organization 
The Influenza A virus genome consists of eight RNA segments encoding 11 
viral proteins.  Specific viral proteins have been assigned to individual RNAs.  
Proteins M2 and NEP/NS2 are derived from the M and NS genes, respectively, and 
are produced as a result of mRNA splicing. The protein PB1-F2 has recently been 
identified (Suzuki, 2006). 
 
2.1.4 Viral Proteins 
Viral Polymerase Proteins. Approximately half of the total genome encodes the 
three viral polymerase proteins; segments 1, 2, and 3 encode PB2, PB1, and PA, 
respectively.  These three proteins contain nuclear localization signals.  In addition to 
the NP proteins, the three viral polymerase proteins constitute the minimum 
complement of proteins required for viral transcription and replication (Honda et al., 
2002). 
 
It has been suggested that polymerase basic protein 1 (PB1) is an RNA 
polymerase; it contains the four conserved motifs of RNA-dependent RNA 
polymerases (Poch et al., 1989).  PB1 contains independent binding sites for PB2 and 
PA.  This polymerase plays a role in the assembly of the three polymerase protein 




The polymerase basic protein 2 (PB2) is transported to the nucleus of infected 
cells where transcription and replication take place (Jones et al., 1986).  PB2 has cap-
binding and endonuclease activity and also contains a binding site for the PB1 protein 
and two regions for binding the NP protein (Poole et al., 2004).  
 
PB2 has also been identified as a determinant of pathogenicity in some 
influenza A viruses and this property is associated with an amino acid mutation at 
position 627 (Hatta et al., 2001). 
 
 The polymerase acid protein (PA) is essential for viral transcription and 
replication, although a specific function for PA has not been described.  It has been 
suggested that PA has helicase and ATP-binding activities and may be involved in the 
protease activity in infected cells (Sanz-Ezquerro et al., 1998). 
 
Hemagglutinin (HA). HA (encoded by segment 4 of the genome) is a type I 
glycoprotein; the hydrophobic carboxy terminus of the protein is embedded in the 
viral membrane and the hydrophilic amino terminal end projects in a spike-like 
fashion away from the viral surface (Knipe, 2007).  The primary function of HA is 
receptor binding via a binding site located within the globular head.  HA binds to 
sialic (N-acetyl neuraminic) acid residues linked to galactose in an α2,3 or α2,6 
conformation.  Avian influenza viruses bind preferentially to sialic acid in the α2,3 
conformation while human influenza viruses prefer an α2,6 linkage conformation 




maintenance of the species barrier of influenza viruses.  Mutations in HA can result in 
changes that affect host specificity and, in this way, could affect the efficiency of 
transmission to humans.  A second important function of HA is fusion under 
conditions of acid pH.  HA is also involved in budding and particle formation. 
 
In chickens, the HA gene is the main determinant of viral pathogenicity.  In 
this regard, the accumulation of basic amino acids at the cleavage site of HA is a 
hallmark of avian influenza viruses having high pathogenic potential (Banks et al., 
2001; Kawaoka et al., 1984).  HA also plays a central role in the host immune 
response to influenza.  HA is recognized by the adaptive host immune system and the 
host produces neutralizing antibodies against HA (Subbarao and Joseph, 2007). 
 
Nucleocapsid protein (NP). Nucleocapsid protein (NP) (encoded by segment 5 of 
the genome) is an arginine-rich protein with RNA-binding activity and its primary 
role is in encapsidation.  NP coats the RNA and is the major viral protein in the 
ribonucleoprotein (RNP) complex. During early stages of infection NP is localized 
predominantly in the nucleus, where it mediates the transport of incoming RNPs from 
the viral particle; in later stages it is found in the cytoplasm, reflecting the trafficking 
of RNPs during the virus life cycle (O'Neill et al., 1995). 
 
Neuraminidase (NA). Neuraminidase (NA) (encoded by segment 6 of the 
genome) is a type II glycoprotein that plays a role in virion release, facilitating 




catalyzes the release of virus particles from the sialic acid-binding sites on the host 
cell (Palese, 2007).  The NA monomer consists of four domains: a globular head, a 
stalk, and transmembrane and cytoplasmic domains.  The NA enzymatic and 
antigenic sites are located in the globular head. 
 
Antibodies specific to NA are not neutralizing but they interfere with virus 
replication by preventing the release of new virus particles (Gulati et al., 2002; 
Subbarao and Joseph, 2007; Webster et al., 1988).  
 
Matrix protein (M). The matrix protein (encoded by segment 7 of the genome)  
of the influenza virus encodes two proteins M1 and M2. M2 is the result of mRNA 
splicing of segment 7. 
 
M1 expression occurs at later stages of virus replication, consistent with its 
role in viral transcription and in exporting RNPs from the nucleus after replication 
(Martin and Helenius, 1991).  M1 is the only viral product that has been shown to be 
an absolute requirement for assembly of virus particles (Gomez-Puertas et al., 2000).  
It has been shown that M1 is necessary and sufficient for the formation of virus-like 
particles, indicating a key role for M1 in the budding process (Gomez-Puertas et al., 
2000).   
 
M2 of influenza A viruses is a tetrameric type III integral membrane protein.  




process (Pinto et al., 1992).  M2 may also play a role in assembly and budding of 
virus particles. The ion channel activity of M2 is the target of the antiviral drug 
amantadine.  M2 has also been considered a vaccine candidate because antibodies 
specific for M2 have been shown to be protective in vivo (Fiers et al., 2004; Treanor 
et al., 1990).  
 
Nuclear structural protein (NS). The nuclear structural protein (NS) gene (segment 
8 of the genome) of influenza A virus encodes two proteins:  NS1, the only non-
structural protein of influenza virus, and NS2, which is encoded by the spliced 
mRNA of segment 8.  NS1 facilitates virus replication and is active early in the virus 
life cycle due to its central role in combating the host immune response (Squires et 
al., 2008).  NS2  is also known as Nuclear Export Protein (NEP), due to its role in 
vRNP nuclear export (Neumann et al., 2000). 
 
2.1.5 Influenza virus replication 
Attachment. The first step in initiation of influenza virus replication is the 
interaction of HA in the globular head of the virus with sialic acid receptors on the 
surfaces of specific cells.  Influenza viruses from different species show different 
preferences for sialic acid.  Human viruses bind preferentially to sialic acid with an 
α2,6 linkage (SAα2,6Gal) whereas avian virus prefer sialic acid with an α2,3 linkage 
(SAα2,3Gal) (Knipe, 2007; Swayne, 2007).  The presence of a specific receptor type 
determines the tissue tropism of an influenza virus. The different steps in the life 








Figure 1.  Life cycle of influenza virus.  (Figure prepared, with modification, from 
Fields Virology, 5th edition, 2008).   Influenza virus attaches to specific viral receptors 
on the cell surface via the glycoprotein HA and is then internalized by receptor-
mediated endocytosis.  In the acidic environment of the endosome, the virus 
undergoes conformational changes that lead to the fusion of the viral envelope and 
the endosomal membranes and activation of M2 ion channel activity.  The vRNP 
segments migrate, via nuclear pores, to the nucleus, where transcription and 
replication of influenza virus takes place. The negative sense vRNA is transcribed 
into mRNA by a primer-dependent mechanism.  Viral replication occurs via a two-
step process catalyzed by the viral polymerase complex and mature RNPs are 
exported from the nucleus.  The plus-strand RNA is transported into the cytoplasm 
for translation into early and late viral proteins.  Following translation and 
posttranslational modifications, the virion is assembled and the newly formed viral 





Entry. Influenza virus enters the cell by endocytosis in a low-pH environment.  
It has been proposed that the primary mechanism by which virus is internalized is 
receptor-mediated endocytosis associated with clathrin-coated pits (Skehel, 2000). 
 
Fusion and Uncoating. The fusion of the influenza virus envelope and 
endosomal membrane requires a low pH.  After a structural change in the HA 
precursor HA0, which results in the cleavage of HA0 into two subunits, HA1 and 
HA2, the fusion activity of HA is initiated (Swayne, 2007).  As a consequence of 
cleavage, the fusion peptide is exposed at the N-terminus of the HA2 subunit, making 
interaction with the endosomal membrane possible.  As a result of this structural 
change in multiple neighboring HA molecules, the content of the virion is released 
into the cytoplasm of the cell through a fusion pore. 
 
The M2 protein participates in uncoating of influenza virus via its ion channel 
activity.  HA-mediated fusion of the viral membrane with the endosomal membrane 
and release of the RNP, mediated by M-2, results in the appearance of free RNP 
complexes in the cytoplasm.  The uncoating process is then complete (Palese, 2007). 
 
Transcription and Replication. As noted earlier, the genome of influenza virus 
consists of single-stranded, negative-sense RNA.  In contrast to other single-stranded,  
negative-sense RNA viruses, transcription and replication of influenza virus takes 
place in the nucleus of the cell.  To initiate synthesis of its mRNA, influenza virus 




5’-capped primer from host pre-mRNA transcripts to initiate mRNA synthesis.  To 
accomplish this, the virus uses the cap-binding function of the PB2 protein and the 
endonuclease function of the PB1 protein (Palese, 2007).  Transcription is initiated by 
binding of the 5’ end of the vRNA to the PB1 subunit.  As a result, the PB2 protein is 
able to recognize and bind the cap structure on host pre-mRNAs.  The 
polyadenylation of influenza virus mRNA is a host-independent process and is 
catalyzed by the same polymerase that is used for transcription (Plotch and Krug, 
1977).  
 
The vRNA serves as a template for both mRNA and cRNA synthesis.  In 
contrast to mRNA synthesis, initiation of cRNA synthesis occurs without a capped 
primer and cRNAs are full-length copies of the vRNA.   Complementary RNAs are 
not transported to the cytoplasm during viral infection.  In further contrast to  mRNA, 
newly synthesized cRNAs and vRNAs are encapsidated (Palese, 2007). 
 
In the second step of replication, the positive-sense cRNA serves as the 
template for the synthesis of negative-sense genomic vRNA in a primer-independent 
reaction. 
 
Virus Assembly and Release. Influenza viruses assemble and bud from the 
apical plasma membrane of polarized cells.  This characteristic has an effect on viral 
pathogenesis and tissue tropism and explains why, in general, influenza virus has a 




2.2 Avian Influenza Infection 
A wide variety of species of birds and mammals are susceptible to influenza A 
virus infection and the 16 HA and 9 NA subtypes have been identified in avian 
species (Alexander, 2000; Fouchier et al., 2005).  Migratory birds, particularly ducks, 
allow circulation of influenza viruses, which maintains the virus in nature (Ito et al., 
1995) and provides the opportunity for avian influenza virus to spread through 
contact of wild birds with chickens (Isoda et al., 2006). 
 
2.2.1 Avian Influenza Virus Pathotypes 
Based on the severity of clinical signs seen in birds, avian influenza viruses 
are classified into two pathotypes, high pathogenic  (HPAI) and low pathogenic 
(LPAI) avian influenza viruses (Alexander, 2000; Subbarao and Joseph, 2007). 
  
As noted earlier, in gallinaceous birds the HA protein is the primary mediator 
of pathogenicity; the amino acid sequence of the proteolytic cleavage site and the 
proximity of carbohydrates to the site determine differences in cleavability (Banks et 
al., 2000; Lee et al., 2007; Subbarao and Joseph, 2007).  Differences in the protease 
cleavability of HAs are responsible for establishing tissue tropism and determining 
whether infection will be systemic (highly pathogenic) or restricted to the respiratory 
and enteric tracts (low pathogenic), based on which proteases recognize the sequence 
that is present (Lee et al., 2007).  In general, HPAI virus HAs have multiple basic 




precursor HA0 of HPAI viruses is achieved by ubiquitous intracellular proteases, 
such as furine and PC6 (Horimoto et al., 1994; Subbarao and Joseph, 2007), which 
are present in multiple cell types in several tissues and organs throughout the body.  
The ubiquity of the enzymes capable of cleaving HA0 allows infection of a wide 
range of tissues and viral replication throughout the organism; consequently, severe 
systemic disease can occur in the infected birds.  LPAI viruses have a single arginine 
at the cleavage site and another basic amino acid at position 3 or 4 from the cleavage 
site.  To replicate, LPAI viruses require the presence of extracellular host proteases 
such as trypsin-like enzymes, which are found in restricted anatomical sites, primarily 
in the respiratory and digestive tract (Banks et al., 2000; Halvorson, 2008; Horimoto 
et al., 1994; Subbarao and Joseph, 2007; Swayne, 2007) which restricts infections to 
these sites.  
 
Only viruses of the H5 and H7 subtypes have been identified as HPAI viruses. 
Viruses are classified as HP if they have an intravenous pathogenicity index (IVPI) 
greater than 1.2 in 6-week-old chickens or cause at least 75% mortality in four to 
eight week-old chickens infected intravenously.  If an H5 or H7 virus does not have 
an IVPI of greater than 1.2 or causes less than 75% mortality in an intravenous 
lethality test, the viral genome should be sequenced to determine whether multiple 
basic amino acids are present at the cleavage site of the HA molecule (OIE, 2006). 
    
The process by which HPAIVs emerge is poorly understood.  It has been 




viruses have been introduced into domestic poultry or the waterfowl reservoir, 
although most evidence supports the former (Banks et al., 2000).  Proposed 
mechanisms for the generation of H5 and H7 HPAI viruses include insertion of extra 
basic amino acids into the HA cleavage site and substitution of non-basic with basic 
amino acids; this was shown for the H5N2 HPAI virus of Mexico in 1994 (Horimoto 
et al., 1995).   Another possible mechanism involves the loss of a sugar group near 
the HA cleavage site; an example of this occurs in the H5N2 HPAI virus that caused 
an outbreak in 1983 in the United States (Kawaoka and Webster, 1985).  A third 
possible mechanism is homologous recombination; this was demonstrated in Chile in 
2002 when an insertion of 27 nucleotides from the NP gene was identified in the HA 
cleavage site of an H7N3 HPAI virus.   Evidence of a similar recombination event 
was observed in the H7N3 HPAI virus, in which an insertion of 21 nucleotides from 
the M gene was identified in 2004 in Canada (Pasick et al., 2005; Suarez et al., 2004). 
 
2.2.2 Disease in poultry. 
Highly Pathogenic Avian Influenza Infection.  The most virulent forms of 
highly pathogenic avian influenza (HPAI) are characterized by a highly fatal systemic 
infection that spreads to most organ systems, including the cardiovascular and 
nervous systems. Depending on the virus and species of bird, the appearance of 
clinical signs and the nature of gross lesions vary.  Clinical presentation varies and 
depends on the extent of lesions to specific organs and tissues.  In domestic poultry 
HPAI viruses produce severe depression, extreme decreases in feed and water 




neurological symptoms if the animals survive the peracute phase.  The incubation 
period is usually between three and seven days, depending on the virus isolate, and 
the age and species of the bird.  If the animals survive longer than seven days, 
nervous system symptoms can appear (Sorrell et al., 2007; Swayne and Suarez, 
2000).  Common lesions include edema to necrosis of comb and wattles, edema of the 
head and legs, lungs filled with fluid and blood, and small hemorrhages on internal 
organs such as coronary fat.  These lesions point to alterations in the cardiovascular 
system, principally affecting vascular endothelium, and the resulting viremia 
(Swayne, 2007).   
 
Low pathogenic avian influenza virus.  LPAI viruses emerged as a cause of 
respiratory disease and reduced egg production in turkeys in Canada and the United 
States during the early 1960’s.  Since then, LPAI viruses of subtype H5 have been 
isolated in Canada in 1966 and in the United States in1968.  
 
Large surveys have resulted in the isolation of LPAI viruses from wild birds 
showing no signs of disease.  Wild aquatic birds, primarily of the orders Anseriforme 
(ducks and geese) and Charadriiforme (shorebirds, gulls, terns, and auks), are 
considered reservoirs of AI viruses (Halvorson, 2008; Suarez, 2000).  Infection with 
an LPAI virus can result in mild to moderate signs of disease or be asymptomatic.  
Domestic birds infected with an LPAI virus usually do not show signs of disease 
during the period when the virus is effectively transmitted, whether in live bird 
markets, backyard flocks, or large or small commercial poultry operations.   LPAI 




the respiratory, digestive, urinary, and reproductive organs.  Respiratory signs are 
usually mild to severe and include coughing, sneezing, rales, and excessive 
lacrimation.  General symptoms include ruffled feathers, depression, decreased 
activity, lethargy, and decreased feed and water consumption (Saif, 2008). 
  
Natural infection by avian influenza virus results in a wide range of clinical 
forms, depending on factors such as the virus strain, host species, age of the bird, and 
environmental factors.  Based on mortality rates and clinical signs and lesions after 
infection with AI virus in the field, four clinical classes of the disease can be 
assigned: highly virulent, moderately virulent, mildly virulent, and avirulent.  The 
highly virulent group results from infection with the H5 and H7 HPAI viruses; 
infection is characterized by systemic disease, with involvement of the cardiovascular 
and nervous systems.  Morbidity and mortality are very high in this group and can 
reach 100%.  The moderately virulent group is the result of infection with LPAI 
viruses and/or co-infection with other pathogens.  The mortality rate ranges from as 
low as 5% up to 97% in young or severely stressed birds.  Lesions may be found in 
the respiratory tract, reproductive system, kidneys, or pancreas.  The mildly virulent 
class of disease results from infection with LPAI viruses; animals with this type of 
disease show mild respiratory symptoms or a drop in egg production and mortality is 
low - usually less than 5%.  The avirulent group corresponds to birds infected with an 
LPAI virus in which no clinical signs or mortality are observed.  During an outbreak 





Avian influenza virus evolves continuously.  New strains are generated as a 
result of the segmented genome, which allows reassortment, and the lack of 
proofreading during vRNA replication.  
 
Host range restriction is considered polygenic but the specific role of each 
gene contributing to determination of host specificity is not known.  Although there 
appears to be a considerable degree of species specificity, the virus has jumped the 
species barrier and can now be found in a broad range of species not previously 
reported (Morgan, 2006).  
 
Wild waterfowl are considered the natural reservoirs of influenza A viruses.  
The virus replicates primarily in the gastrointestinal tract.  Virus is shed into the 
feces, which allows transmission between wild birds as a result of fecal 
contamination of water (Webster et al., 1978).  Geographic dissemination of virus by 
infected migratory birds is potentially very extensive (Morgan, 2006).  Trade and 
illegal smuggling of poultry are also a means of disseminating the virus. 
 
Outbreaks have occurred frequently over the last decade in North America, 
Europe, and Asia.  In Asia, HPAI H5N1 influenza viruses have been recognized since 
1996 (Isoda et al., 2006; Li et al., 2004; Sims et al., 2003; Xu et al., 1999).  In 1997, 
HPAI viruses were directly transmitted from birds to humans in Hong Kong (Suarez 
et al., 1998).  This first incidence of an H5 influenza virus being isolated from 




The H5N1 isolates originated completely from an avian virus; this is in contrast to the 
1957 and 1968 pandemic strains, which were reassortants (Claas et al., 1998; 
Subbarao et al., 1998).    
  
Currently there is no evidence of HPAI strains, including H5N1, in the United 
States.  Historically, there have been three outbreaks of infection with HPAI virus in 
poultry in the US.   In 1924 an outbreak was caused by an H7 virus that originated in 
live-bird markets in the eastern part of the country and, in 1983-84, the outbreak was 
traced to an H5N2 in the northeastern US (Bean et al., 1985).  In 2004 an outbreak 
caused by infection with H5N2 occurred in the southern part of the country; this virus 
was classified as HPAI based on the the amino acid sequence of the HA (Lee et al., 
2005).   
  
The impact of HPAI virus infections is not limited to the high mortality and 
economic losses, but also includes the possibility of origination of new viruses with 
wider host ranges and pandemic potential.  
 
Pathogenicity of AI strains in chickens do not necessarily correlate with 
pathogenicity in other species, such as pigs, indicating that factors involved in host 
range restriction may reside in parameters other than the structure of the HA. 
 
Low-pathogenic AI outbreaks have caused significant economic losses for 




bacterial infections as a result of a primary AI virus infection.  Mortality, 
condemnation of carcasses, disinfection, and delayed placement of new birds also 
contribute to the economic losses  (Halvorson, 2008).  
 
2.2.4 Immune Response 
Although the influenza virus has developed mechanisms to counteract the 
initial immune response to viral infection, elimination of the virus is carried out by a 
combination of innate and adaptive immune responses. 
   
Infection with AI viruses, as well as immunization with vaccines, results in a 
humoral antibody response.  HA and NA induce production of neutralizing and 
protective antibodies.  Internal viral proteins may induce an immune response that, 
although it does not prevent clinical signs, could reduce the period of virus replication 
and shedding (Halvorson, 2008).  
 
Influenza viruses have the ability to generate new strains through 
accumulation of mutations.  The mechanism by which these changes affect the 
efficiency of the innate immune response is not completely understood.  In this 
regard, the innate immune response plays a major role in counteracting the initial 
infection.  Invasion of cytotoxic CD8-positive T cells into the lungs is critical for 
viral clearance.  Cellular components of the innate response to influenza A virus 
infection includes NK (natural killer) cells, macrophages, and neutrophils.  The role 




Macrophages produce chemokines and cytokines during influenza A virus infection 
in vivo, resulting in a protective or deleterious effect during the infection (Wijburg et 
al., 1997).  It is necessary to determine the contribution of macrophages, as opposed 
to other leucocytes or epithelial cells, to the immune response in influenza infections 
(Tecle, 2005).  
 
The innate immune response must effectively control viral replication without 
inducing an excessive inflammatory response, which can potentially cause damage to 
the lungs (Tecle, 2005).  It has been proposed that differences in the outcome of 
influenza A virus infections in humans could be related to innate immune response; 
outcomes would be influenced if the innate immune response wasimpaired or resulted 
in a severe inflammatory process. It has been proposed that influenza A virus 
infection activates the inflammatory responses of respiratory epithelial cells via a 
pathway involving TLR3 (Toll-like receptor 3) (Guillot et al., 2005).  Influenza A 
virus induces IL-8 (Interleukin-8), IL-6 (Interleukin-6) and RANTES (regulated upon 
activation, normal T cell expressed and secreted) protein expression, as well as 





2.3 Infectious Bursal Disease (IBD) 
Infectious Bursal Disease (IBD) is a highly contagious, immunosuppressive 
infection of young chickens.  IBD is also known as Gumboro disease because the first 




The etiologic agent of IBD is infectious bursal disease virus (IBDV), which 
belongs to the family Birnaviridae and the genus Avibirnavirus (Muller et al., 2003).  
The IBDV genome consists of two segments of double-stranded RNA enclosed in a 
non-enveloped icosahedral capsid (Hirai and Shimakura, 1974; Nick et al., 1976).  
 
 There are two serotypes of IBDV, which can be differentiated by a virus 
neutralization test (McFerran et al., 1980).  Both serotypes are present in chickens but 
only strains of serotype 1 are associated with disease (Ismail and Saif, 1991). 
 
2.3.2 Virion. 
The virion consists of two segments of double-stranded RNA encoding five 
proteins.  The small segment B encodes the vRNA polymerase VP1, and the large 
segment A encodes VP2, VP3, VP4, and VP5.  VP2 and VP3 are the major structural 
proteins and VP2 contains the major neutralizing epitopes.  VP4 is a nonstructural 
protein and has protease activity associated with cleavage of the progenitor 




assigned but a regulatory function involved in virus release and apoptosis has been 
suggested (Liu and Vakharia, 2006). 
 
2.3.3 Disease in chickens 
Infectious Bursal Disease (IBD) is one of the most prevalent diseases in the 
poultry industry.  This virus is restricted to chickens and has varying degrees of 
pathogenicity in the field; although turkeys and ducks can be naturally infected with 
IBDV, they do not develop signs of disease.  Flocks infected with IBDV do not 
perform well, due to the immunosuppressive effects of this virus, and show reduced 
economic return and severe losses (Farooq, 2003; Lutticken, 1997; Saif, 1991; Saif, 
2008). 
 
IBD in chickens can appear in an acute lethal form but, depending on the host 
cell in which the virus replicates, disease with variable degrees of severity can occur.  
Clinical signs are nonspecific and include diarrhea, anorexia, depression, and ruffled 
feathers; the severity of the signs and degree of mortality are variable and depend on 
several factors in addition to the virulence of the virus strain. 
  
IBDV primarily targets the lymphoid tissue in the bursa of Fabricius; this 
affects mainly humoral immunity, due to the virus’s predilection for B lymphocytes 
or their precursors, but secondary lymphoid organs, such as the cecal tonsil and the 
spleen, as well as macrophage activity can also be affected (Kaufer and Weiss, 1980).  
IBDV infection can result in impaired humoral and local immune responses, with the 




infected bird. Chickens infected with IBDV early in life do not show clinical signs 
but have subclinical infections and compromised humoral and local responses 
(Balamurugan and Kataria, 2006).  It has been shown that chickens infected at one 
day of age are deficient in serum immunoglobulin G and produce only monomeric 
IgM.  The number of peripheral blood B cells is also reduced following IBDV 
infection (Ivanyi and Morris, 1976).  Chickens are more susceptible to disease when 
the infection occurs between three and six weeks of age, resulting in clinical signs, 
severe bursal atrophy and immune suppression. In addition, IBDV infection can have 
a transient effect on cell-mediated immune responses but this is not as evident as the 
effect on the humoral immune response (Craft et al., 1990; Sivanandan and 
Maheswaran, 1980; Saif, 2008).  
 
The effect of IBDV on the immune response was reported many years ago in 
relation to the reduced ability of infected chickens to respond to vaccination and 
demonstration of exacerbated infections with other pathogens; in contrast, the 
response to IBDV itself is normal (Bracewell et al., 1972; Faragher et al., 1974; Hirai 
et al., 1974; Rosenberger and Gelb, 1978; Muller et al., 2003;  Fadly et al., 1976; 
Sharma, 1984).  
 
Since 1986, when a variant of IBDV emerged as a consequence of antigenic 
shift in viruses belonging to serotype 1, IBDV has been classified as classical, variant 
or very virulent (Snyder et al., 1988).  Antigenic variants, such as the GLS and 




virulent strains of IBDV, characterized by high mortality and lesions in organs such 
as the bone marrow and thymus, appeared in several European and Asian countries.  
The variants induce disease in chickens in the presence of antibodies to vaccine 
strains of serotype 1, also known as classical strains.  The presence of these variant 
viruses is a challenge to control of IBD because classic serotype 1 viruses provide 
only partial protection against variants of these viruses.  In contrast, variant viruses 
provide complete protection against both classical and variant viruses (Ismail and 
Saif, 1991; Wu et al., 2007). 
 
IBDV vaccines are grouped on the basis of their residual virulence into mild, 
mild intermediate, intermediate, and intermediate plus or hot strains (Saif, 2008).  
IBDV intermediate vaccine strains vary in their virulence and can have an effect on 
the immune status of chickens with a detrimental effect on the immune response due 
to a suboptimal response to vaccination (Muller et al., 2003; Rautenschlein et al., 
2007). 
 
In general, variant viruses induce few or no clinical signs of disease but target 
primarily the bursa of Fabricius.  Classical strains induce mortality rates between 2% 
and 15% and can reach 50%, showing clinical signs and lesions.  Infection with very 
virulent strains can result in mortality rates between 50% and 100%, with clinical 








Pathogenicity of avian influenza virus is related to both host and viral factors.  
Low pathogenic avian influenza virus (LPAIV) circulates in wild birds that serve as 
natural reservoirs of influenza viruses.  It is generally accepted that those birds are a 
potential source for new viruses to emerge, cross host barriers, and infect new avian 
or mammalian species. During this process changes in pathogenicity occur, resulting 
in different disease outcomes in animals infected with the viruses.  In this regard, the 
immunological status of the host is considered a predisposing factor that could 
contribute to differences in disease susceptibility and/or viral pathogenicity.  In order 
to understand host factors involved in susceptibility to infection by avian influenza 
virus we study the effect of pre-exposure to IBDV (infectious bursal disease virus) on 
the adaptation of a mallard H5N2 LPAIV in chickens.  We found that a dose of 5 x 
106 EID50 (50% egg infectious dose) did not replicate at all in normal chickens and 
replicated inefficiently in IBDV-pre-exposed chickens; however, passage of the 
mallard H5N2 LPAIV in IBDV-pre-exposed chickens resulted in a virus that 
replicated efficiently, causing clinical signs and severe lesions in the respiratory tract 
of IBDV-pre-exposed chickens.  When tested in other avian species the P22 
(passaged 22 times) adapted virus replicated more efficiently than the wild-type (WT) 




pheasants at 3 dpi.  Results of this study showed that pre-exposure of the host to 
IBDV might play a role in adaptation and/or pathogenicity of avian influenza virus. 
 
3.2 Introduction 
Influenza A viruses can be assigned to two main pathotypes based on their 
virulence: the highly pathogenic viruses, which cause severe systemic disease in 
poultry, and the low pathogenic viruses which cause mild or no signs of disease.  
Influenza virus virulence is a polygenic trait but it is also influenced by host factors.  
The association of both virus genetic and host factors determines the outcome of 
influenza virus infection. 
 
A major outbreak caused by an H5N2 HPAI virus (A/Chicken/Penn/83) 
occurred in the United States in 1984, killing approximately 17 million birds and 
infecting primarily chickens and turkeys (Halvorson, 2008; T. Horimoto, 1995; 
Wood, 1984).   The origin of the virus has not been conclusively determined, 
however it is antigenically similar to viruses isolated from wild ducks in Canada and 
the United States.  There is evidence that the virus was either circulating in wild 
ducks or that it was present in other water birds (Wood, 1984).  It was also 
determined that H5N2 viruses isolated in 1985 and 1986 in the US were genetically 
related to the virus isolated in 1983-84 in Pennsylvania; those viruses originated from 
birds in live-poultry markets in New York City, New Jersey, and Miami, FL 
(Kawaoka and Webster, 1988a).  Based on epidemiological and experimental data, it 




probably occurred during the emergence of the HPAI virus.  The H5N2 virus, which 
initially behaved as a low pathogenic avian influenza virus with a low mortality rate, 
underwent changes over a period of six months and became highly pathogenic in 
chickens, resulting in a virus with mortality increased up to 80% (Wood, 1984).  As 
mentioned earlier, a LPAI virus is considered the ancestor of the H5N2 HPAIV and a 
selective mechanism of adaptation has been proposed (Bean et al., 1985). 
 
Considering host factors and their effect on susceptibility to viral infection, 
host immune status is one parameter that has been associated with increased 
susceptibility to viral and bacterial infections.  In this regard, infectious bursal disease 
(IBD) is a condition that affects immune status in chickens.  IBD represents a major 
economic concern for the poultry industry due to its prevalence in most poultry-
producing areas of the world (Sharma et al., 2000); the prevalence of IBD is the 
reason that most commercial chickens are exposed to IBDV early in life.  Both broiler 
and layer flocks are susceptible to the immunosuppressive effects of the virus 
(Sharma et al., 2000), with humoral and cellular immune responses being 
compromised (Saif, 1991).  The main consequence of IBDV  infection is 
immunosuppression and this effect is greater when the chicks are infected at 1 day of 
age (Higashihara et al., 1991).  However little is known of the potential effects of host 
pre-exposure to IBDV on susceptibility to subsequent AIV infection and on 
associated clinical signs, lesions, and virus shedding.   For this reason, and due to the 




effect of pre-exposure to IBDV at an early age on the susceptibility of chickens to 
AIV infection and on the adaptation of AIV from wild birds into land-based poultry. 
 
We wanted to determine if the virus used in this study, an H5N2 mallard 
virus, which is antigenically very similar to the H5N2/Pennsylvania/83 avian 
influenza virus that caused the outbreak in Pennsylvania in 1983 (Bean et al., 1985), 
was capable of replication in chickens without prior adaptation.  To address this, we 
inoculated SPF (specific-pathogen-free) White Leghorn chickens with a dose of 
5x106 EID50 by ocular-nasal and tracheal routes.  Interestingly, we did not see 
replication in the SPF chickens after several attempts.  
 
In our effort to elucidate the mechanisms involved in the generation of 
pathogenic variants from low pathogenic influenza viruses and, considering IBDV 
infection a predisposing factor, we wanted to determine if pre-exposure to IBDV 
facilitates the adaptation and/or increases the pathogenicity of the mallard AI virus in 
chickens. 
 
This chapter presents a description of the experimental methods used and 
results obtained during the adaptation of the A/mallard/Pennsylvania/84 H5N2 
LPAIV in IBDV-pre-exposed chickens.  
 
Analysis of host range restriction factors and virus adaptation mechanisms 




and generation of new variants – an event with potentially deleterious consequences 
for the poultry industry because of the possibility that new variants will be more 
highly pathogenic than existing strains. 
 
3.3 Materials and Methods 
3.3.1 Viruses 
Low Pathogenic Avian Influenza Virus: The A/Mallard/ 
Pennsylvania/12180/84  (H5N2) used in this study was obtained from the repository 
at St. Jude Children’s Research Hospital, Memphis, TN, USA.  The virus was 
propagated in 10-day-old embryonated specific-pathogen-free (SPF) chicken eggs 
and titrated to determine the 50% egg infectious dose  (EID50) by the Reed and 
Muench  method  (Reed, 1938). 
 
Infectious Bursal Disease Virus: IBD E-Delaware variant virus was used to 
infect chickens at an early age in order to determine the effect of pre-exposure to 
IBDV on the susceptibility of chickens to avian influenza virus infection.  Virus stock 
was prepared in 3-week-old SPF White Leghorn Chickens (Charles River 
Laboratories, Wilmington, MA, USA) that were infected by ocular, intranasal, and 
oral routes with 200 µl of IBDV stock diluted 1:10 in TPB (Tryptose Phosphate 
Broth, Sigma-Aldrich, St. Louis, MO, USA) containing Antibiotic - Antimycotic 
solution (100X) (Sigma-Aldrich, St. Louis, MO, USA). Bursa and body weights were 
recorded to determine the bursa/body weight index.  Bursas were collected at 24, 48, 




Immunosorbent-Assay (ELISA) (IBDV Antigen-capture ELISA Test Kit, Synbiotics 
Corporation, San Diego, CA, USA).  The maximum concentration of viral antigen 
was obtained from bursa homogenate prepared at 48 h post-infection.  The 50% 
chicken infectious dose (CID50) for the IBDV stock was determined. 
 
3.3.2 Tissue Homogenates 
3.3.2.1 Bursa homogenate.  The bursa of Fabricius was extracted through an 
incision on the back of the chicken, washed in PBS containing Antibiotic – 
Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO, USA), and weighed.  A 
sample was preserved in 10% buffered formalin for hematoxylin-eosin staining and 
histological analysis.  The remaining tissue was cut into small pieces using scissors.  
An equal volume of antigen dilution buffer or TPB containing Antibiotic – 
Antimycotic (100X) (Sigma-Aldrich, St. Louis, MO, USA) was added and a layer of 
sterile laboratory sea sand (Fisher Scientific, Waltham, MA, USA) was added to the 
mixture.  The sample was ground using a pestle.  The homogenized tissue was frozen 
at -70 ºC and thawed three times, briefly vortex-mixed, and centrifuged at 1500 x g at 
4 ºC for 10 min.  The supernatant was collected, aliquoted into 1.5 ml microfuge 
tubes and stored at -70 ºC until use. Presence of the virus in the bursa homogenate 
was established by ELISA (IBDV Antigen-capture Elisa Test Kit, Synbiotics 
Corporation, San Diego, CA, USA) according to the manufacturer’s instructions. 
 
3.3.2.2 Lung Homogenate. Lungs were extracted and washed twice in PBS-
Antibiotic - Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO) to remove 




to a mortar and cut into small pieces using scissors.  A layer of sterile laboratory sea 
sand (Fisher Scientific, Waltham, MA, USA) was added to the tissue and the sample 
was ground using a pestle.  A 10% (w/v) lung homogenate suspension was prepared 
by adding corresponding amount of Brain Heart Infusion (BHI) broth (BHI powder 
(BBL Cat. no. 211060) containing Gentamicin and Antibiotic - Antimycotic solution 
(100X) (Sigma-Aldrich, St. Louis, MO).  The homogenate was centrifuged at 1500 x 
g, at 4 ºC for 10 min and the supernatant was collected and filtered using a 0.22 µm 
filter unit.  Aliquots of the homogenate were stored at –70oC until use. 
   
3.3.2.3 Soft Tissue Homogenates: Brain, Kidney, Intestine, Pancreas, Liver,  
Spleen.  After collection the tissue was washed twice in PBS plus Antibiotic - 
Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO) and then placed in 
sterile tissue bags and weighed.  A tissue homogenate was prepared using a 
laboratory blender  (Seward Stomacher®80, Lab System). The samples were 
transported on ice and the machine was run for 1 - 2 minutes at a time until the tissue 
was completely homogenized.  BHI medium (BHI powder (BBL Cat. no. 211060) 
Gentamicin, and Antibiotic - Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, 
MO) was added to make a 10% (w/v) homogenate.  The tissue homogenate was 
centrifuged at 1500 x g at 4 ºC for 10 min and the supernatant was filtered using a 





3.3.3 Animals and Experimental Infections 
SPF White Leghorn chickens (Charles River Laboratories, Wilmington, MA, 
USA) were used.  Avian influenza virus was administered in doses of 1 ml at a 
concentration of 5 X 106 EID50/ml and 1 X 108 EID50/ml.   Infection routes were 
through the nares, eyes, trachea, and cloaca.  Animal feeding needles (Fisher 
Scientific, Waltham, MA, USA) were used to administer the virus.  Tracheal and 
cloacal swabs were collected on alternate days and stored in glass vials containing 1 
ml glycerol medium (50% sterile glycerol, 50% PBS, 1 ml/200 ml total volume 
Gentamycin, 10 ml 100X Antibiotic – Antimycotic (100X) (Sigma-Aldrich, St. Louis, 
MO, USA]) at -70 oC.   Swab samples were tested for presence of virus by passing 
swab medium in 10-day-old embryonated chicken eggs.  Three eggs were used for 
each swab collected and 200 µl medium was used to infect each egg.  Infected eggs 
were incubated for 48 h and then chilled at 4 oC for no more than 24 h or at -20oC for 
30 min.  Allantoic fluid was collected and a hemagglutination assay was performed, 
following World Health Organization (WHO) recommendations, to determine the 
presence of virus.  Samples showing agglutination of chicken red blood cells were 
scored as positive. 
 
 Birds were observed and scored daily for clinical signs of disease and general 
well being.  Animals were evaluated on the basis of appetite, activity, fecal output, 
and signs of distress or clinical illness, including ruffled feathers and respiratory 
distress. Birds were scored on a scale of 1 to 4.  Table 1 shows the scoring sheet and 




 Experiments were carried out under BSL2+ conditions, with investigators 
wearing appropriate personal protective equipment, and were compliant with animal 
protocols approved by the Institutional Animal Care and Use Committee (IACUC) of 
the University of Maryland, College Park, MD, USA and Animal Welfare Act 
(AWA) regulations. 
 
3.3.4 H5N2 LPAI virus passages in IBDV- pre-exposed chickens   
Two-day-old SPF chickens were infected with 100 CID50 of the E-Delaware 
IBD virus strain by oral and ocular routes.  Adaptation experiments consisted of 22 
passages of A/mallard/Pennsylvania/12180/84 (H5N2) virus in three-week-old 
IBDV-pre-exposed chickens.  The dose for the first passage was a 1:10 dilution of 
H5N2 wild-type viral stock that had been grown once in embryonated chicken eggs.   
Subsequent passages were carried out by inoculation with a 10% pooled lung 
homogenate from the previous passage, with the exception of passages 16, 18, and 
19, where a 1:10 dilution of allantoic fluid collected from the lung homogenate 
inoculation in chicken embryonated eggs was used as the inoculum for the next 
chicken passage.  Tracheal and cloacal swabs were collected on days 1 and 3 post-
infection and virus was detected using a hemagglutination assay.  Doses of 1 ml were 
administered to the chickens.  One milliliter aliquots of lung homogenate from each 
































1 = Ruffled feathers
2 = Light/Mild swelling of the face or legs




1 = alert but only when personnel enters the room and/or works around the cage
2 = alert but only when stimulated
3 = inactive, not responding to stimuli
 
Respiratory disease symptoms:
0 = no symptoms
1 = light nasal discharge
2 = heavy nasal discharge/conjunctivitis
3 = mouth breathing/labored breathing/wheezing
 
Other disease symptoms/body weight loss




3.3.5 Dose preparation from lung homogenate  
Lungs were collected on day 3 post-infection and a 10% (w/v) lung 
homogenate was prepared by adding corresponding amount of Brain Heart Infusion 
(BHI) broth as described in 3.3.2.2.  The next chicken passage was infected with the 
10% pooled lung homogenate as described in 3.3.4.  Doses of 1 ml were administered 
using sterile animal feeding needles  (Fisher Scientific, Waltham, MA, USA).  
Approximately 200 µl were administered in the eyes, 200 µl in the nares, 400 µl in 
the trachea, and the remaining 200 µl in the cloaca.  Pooled lung homogenate was 
titrated in embryonated chicken eggs to determine virus concentration in each of the 
doses. 
 
Allantoic fluid from pool lung homogenate inoculated in embryonated eggs 
was used for infection in passage 16, 18, and 19 was diluted 1:10 with PBS/Antibiotic 
- Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO). 
 
3.3.6 Transmission of influenza virus in chickens 
For transmission experiments, three SPF White Leghorn chickens, three to 
four week of age, were infected with virus at a concentration of 1 X 108 EID50 in a 
volume of 1 ml as described in 3.3.5. Three contact birds were introduced at 1 dpi 
into the cage with the infected chickens.  Water and food, as well as cage liners, were 




cloacal swab samples were collected 1, 3, 5, 7, and 9 dpi and hemagglutination assays 
were conducted to determine extent of viral shedding. 
 
3.3.7 Replication of the mallard H5N2 WT and P22 chicken-adapted LPAI virus  
in turkeys and pheasants.  
In order to determine if adaptation of the H5N2 mallard virus in IBDV-pre-
exposed chickens resulted in a virus that replicates more efficiently than in other 
avian species, we tested the replication of the WT and P22 adapted virus in the 
respiratory tract of turkeys and pheasants.  To achieve this the avian influenza viruses 
were administered in doses of 1 ml at a concentration of 1 X 108 EID50/ml to groups 
of two (WT) or three (P22) turkeys and groups of three (WT and P22) pheasants.   
Infection routes included the nares, eyes, trachea and cloaca, following the same 
procedure described previously in section 3.3.5 for chickens.  Animal feeding needles 
(Fisher Scientific, Waltham, MA, USA) were used to administer the virus. Tracheal 
and cloacal swabs were collected on alternate days and stored in glass vials 
containing 1 ml glycerol medium (50% sterile glycerol, 50% PBS, Gentamycin 
(Sigma-Aldrich, St. Louis, MO), Antibiotic – Antimycotic solution (100X) (Sigma-
Aldrich, St. Louis, MO) at -70oC.  Swab samples were tested for virus by passing 
swab medium in 10-day-old embryonated chicken eggs, following the same 
procedure as described in 3.3.3.  Lung homogenates were prepared from each animal 
at 3 dpi, following the same procedure as described in 3.3.2.2, and titrated to 





 Birds were observed and scored daily for clinical signs of disease and general 
well being using the same criteria as for chickens (Table 1).  Experiments were 
carried out under BSL2+ conditions, with investigators wearing appropriate personal 
protective equipment, and were compliant with animal protocols approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of 
Maryland, College Park, MD, USA and Animal Welfare Act (AWA) regulations. 
 
3.4 Results 
3.4.1 The mallard H5N2 LPAI virus replicates efficiently after passage in IBDV-
pre-exposed chickens 
Inoculation with a dose of 5 x 106 EID50 A/mal/Penn/84/H5N2 virus in 2 to 3-
week-old normal SPF White Leghorn chickens resulted in no replication and no 
transmission of the virus.  The same experiment was repeated four times with similar 
results.  When the same dose of virus was used in IBDV-pre-exposed chickens there 
was poor transient replication of the LPAIV. 
 
Different routes of inoculation and virus dose were evaluated.  Initially only 
ocular-nasal and intratracheal routes of inoculation were attempted, but later an 
intracloacal route was added.  Infection with a dose of 1x108 EID50 of the WT virus 
resulted in virus appearing in the lungs of infected chickens.  Considering host 
immune status as a determinant for an animal’s susceptibility to infectious agents, 
adaptation of H5N2 LPAIV was conducted in chickens that had been pre-exposed to 




from tracheal swabs. However, during and after passage five, virus was found not 
only in the trachea but also in the cloacae.  At the same time there was an increase of 
approximately 1 log10 in virus titer in lung homogenate (Table 2). 
 
3.4.2 Clinical signs and macroscopic findings suggest an increase in 
pathogenicity during adaptation in chickens pre-exposed to IBDV  
Gross lesions found at necropsy included fibrinous airsacculitis after a low 
number of passages, with severity increasing after 10 passages.  A similar pattern was 
observed in lung lesions and was consistent with clinical outcome.  During the first 
13 passages none of the virus-inoculated chickens presented clinical signs or died; at 
passage 14 one of three animals showed the first evidence of clinical signs - sneezing 
at days two and three post-infection.  This and another animal from the same group 
showed cloudy eyes and periorbital edema.  Respiratory signs were observed again in 
chickens infected at passage 16 and were present and very evident in 3/3 infected 
chickens in passage 18.  Animals showed respiratory distress, sneezing, and cloudy 
eyes.  With continued adaptation, mild respiratory signs became more severe after 
passage 22.  There was an increase in virus titer in lung and in virus shedding in 
trachea.  During adaptation the virus titer in the lung peaked at 106.6 EID50/ml (Figure 
2).  The chickens shed more virus from the trachea than from the cloaca, providing an 
explanation for the respiratory signs observed after passage 22 (P22) in IBDV-pre-
exposed animals.  As expected, a constant finding was atrophy of the bursa of 






Table 2.  Virus shedding in trachea and cloaca and virus titers in pooled lung 


























P1 + + + - - - 4.5 
P2 + - - - - - 4.5 
P3 - + - - - - 4.5 
P4 + + - - - - 5.7 
P5 + + + + - - 5.5 
P6 + + + + - - 6.5 
P7 - + + + + + 5.5 
P8 + + + - - - 6.5 
P9 + + - + + + 5.5 
P10 - + + + + + 6.0 
P11 + + + + - - 6.2 
P12 + + + + - + 6.5 
P13 + + + - + - 6.2 
P14 + + + + + + 6.2 
P15 + + + + + + 6.2 
P16 - + + + + + 6.2 
P17 + + + + + + 6.2 
P18 + + + + + + 6.7 
P19 + + + - + + 6.6 
P20 + + + + + + 6.2 
P21 + + + + + + 6.2 











Figure 2.  Virus titers in the lung during adaptation of a mallard H5N2 AI virus in 
IBDV-pre-exposed chickens.  Groups of three chickens pre-exposed to IBDV were 
inoculated with a 1:10 dilution of pooled lung homogenate from the previous passage. 
Values represent the mean and standard deviation of virus titers in lung homogenates 














3.4.3 Differences in the outcomes of replication and transmission studies were 
observed when comparing different passages  
Macroscopic examination and clinical observation suggested an expansion of 
tissue tropism during the adaptation of the H5N2 AI virus and, on that basis, the 
range of tissues tested for virus isolation was expanded. Brain homogenate was 
evaluated from passages 10 to 19, resulting in 25/30 positive samples. Pancreas 
homogenates analyzed from passages 17 to 19 were 100% positive (9/9) for virus 
isolation.  We then wanted to determine whether the increase in virus replication and 
broader tissue tropism were reflected in more efficient transmission to contact birds.  
With this goal, replication and transmission studies in IBDV-pre-exposed chickens 
were conducted at passage 10, 17, and 22.  Results of this experiment showed 
isolation of virus from tracheal and cloacal swabs from infected animals until 7 dpi, 
as well as occasional transmission to contact animals, with virus isolated from 
tracheal and cloacal swabs only when chickens were infected with virus in lung 
homogenates from passage 17 (Table 3). 
 
3.4.4 P22 AI virus replicates efficiently in turkeys and pheasants  
Adaptation of the mallard H5N2 virus in IBDV-pre-exposed chickens resulted 
in a virus that replicates efficiently, not only in chickens, but also in other avian 
species such as turkeys and pheasants.  Efficient replication in the respiratory tract 
was observed after infection with the WT and P22 viruses; however more than a two-
log10 difference in virus titer was found in the lungs of both turkey and pheasant 










Table 3. Replication and transmission studies in IBDV pre-exposed chickens at 





















No. positive chickens /total No. of  chickens 






Group  Trachea Cloaca Trachea Cloaca Trachea Cloaca 
Infected 3/3 2/3 1/3 1/3 0/3 0/3 P10  
Contact 0/3 0/3 0/3 0/3 0/3 0/3 
Infected 3/3 3/3 3/3 2/3 1/3 0/3 P17 
Contact 1/3 2/3 0/3 0/3 0/3 0/3 
Infected*  3/3 3/3 3/3 2/3 0/1 1/1 P22  










Figure 3.  Replication of WT and P22 AI virus in the lungs of 3-week-old turkey and 
pheasant.  Samples were collected from groups of three birds at 3 dpi with the P22 
and WT viruses.  Titration was performed in inoculated embryonated chicken eggs 
with EID50.  Values represent the average and standard deviation of the titer for 
individuals in each group of three birds.  The results for WT in turkey represent the 







Several factors must converge for a virus to become adapted and transmit into 
a new host. The route of exposure and dose of the virus should be appropriate to 
permit infection.  A series of genetic changes in the virus, which increase the 
efficiency of infection, as well as secondary factors that enhance host susceptibility to 
infection, provide the opportunity for avian influenza virus to successfully adapt. 
 
It has been shown that the immune status of the host influences the outcome 
of viral respiratory diseases in poultry (Rosenberger and Gelb, 1978).  To elucidate 
the role of host immune status on the susceptibility of chickens to avian influenza 
virus, we analyzed a mallard H5N2 LPAIV in IBDV-pre-exposed chickens.   We 
evaluated the effect of passing inoculation of the LPAIV in birds that had been pre-
exposed to IBDV, using natural routes of infection, to determine whether this 
facilitates replication and transmission among susceptible chickens.  Changes in virus 
shedding and replication were observed, with virus replicating preferentially in the 
respiratory tract of chickens. Although few or no clinical signs were observed in the 
birds monitored during 3 dpi throughout the 22 passages, when the animals were 
observed for a longer period of time disease signs were evident in IBDV-pre-exposed 
chickens after passage 22, indicating a change in virus pathobiology.   Respiratory 
signs were observed in the infected animals and a significant increase in virus titer 
was observed 3 dpi.  The appearance of clinical signs, efficient replication, and 
increase in virus titer after 22 passages in IBDV- pre-exposed chickens suggests 




The results of this study show that pre-exposure of animals to IBDV 
facilitated adaptation of LPAIV from wild birds into land-based poultry.  Clinical 
signs and virus titers were consistent with a virus that had acquired not only a broader 
tissue tropism in chickens, but also the potential to expand its host range, as shown 
for a 2 to 3-log10 increase in virus titers in lung from turkeys and pheasants when 
compared the P22 and WT AI viruses.  
 
Results of this research suggest an important role for immune status in the 
adaptation of LPAIV in terrestrial birds.  Predisposing factors, such as IBDV 
infection at an early age, should be considered risk factors for generation of virus 
with increased pathogenicity when LPAI strains circulate in a population of birds 
with suboptimal immune status, which is likely to be a common event in nature.  
 
Analysis of changes in pathogenicity as a result of adaptation of the H5N2 AI 
virus in IBDV-pre-exposed chickens, as well as host molecular factors involved in 







Chapter 4: A mallard H5N2 low pathogenic avian influenza virus 




In previous studies we found that passage of a mallard H5N2 low pathogenic 
avian influenza virus (LPAIV) in chickens that had been pre-exposed to infectious 
bursal disease virus (IBDV) resulted in a more efficiently replicating virus, 
suggesting that the adapted virus might also show an increase in pathogenicity in 
IBDV-pre-exposed compared to normal chickens.  Therefore, we analyzed the 
outcomes of infection with wild-type (WT) and P22 (22 passages) adapted AI virus in 
normal and IBDV-pre-exposed chickens by examining the lesions caused by the two 
viruses at the microscopic level in a time-point study.  Analysis of histological data 
from a comprehensive group of tissues showed that IBDV pre-exposure might play a 
role in determining pathogenicity of avian influenza virus.  Detection of viral antigen 
by immunohistochemistry confirmed the presence of virus mainly in inflammatory 
infiltrates, primarily in the respiratory tract of P22 AIV- infected chickens.  We also 
investigated changes in the virus at the molecular level by comparing the sequences 
of the open reading frames in the WT and the P22 AI adapted virus genomes.  Amino 
acid substitutions occurred primarily in the surface glycoprotein HA, suggesting 





The factors that determine interspecies transmission and pathogenicity of 
influenza viruses are still poorly understood.  A large variety of avirulent influenza 
viruses are maintained in wild birds, which are considered the principal reservoir of 
influenza virus (Humberd J et al., 2006; Ito et al., 2001; Rott et al., 1976; Vines et al., 
1998).  These birds provide a large reservoir from which new viruses can emerge and 
infect other mammalian or avian species (Perdue and Swayne, 2005; Silvano et al., 
1997; Webby and Webster, 2001).  Virulence is considered a polygenic property 
(Rott et al., 1979; Scholtissek et al., 1977a; Scholtissek et al., 1977b).  In this regard, 
the surface glycoprotein hemagglutinin (HA) plays a central role determining host 
range while contributing to the virulence of avian influenza viruses (Ito et al., 2001; 
Rott et al., 1976; van der Goot et al., 2003).  It has been shown that the internal genes 
coding for RNA polymerase (PB2, PB1, PA), nucleoprotein (NP), matrix protein 
(M1, M2), and nonstructural protein (NS1, NS2/NEP) also contribute to determining 
host range. 
 
Most influenza virus infections in poultry are subclinical, producing only mild 
to moderate signs of disease.  These avian influenza viruses (AIVs) have been 
categorized as nonpathogenic (NP) or mildly pathogenic (MP).  However some avian 
H5 and H7 viruses cause severe systemic disease associated with high rates of 
morbidity and mortality; these strains are classified in the category of high 
pathogenicity avian influenza (HPAI) virus (Bean et al., 1985; Horimoto et al., 1995; 




It has been proposed that highly pathogenic avian influenza viruses may be 
derived from nonpathogenic avian strains that have acquired mutations which render 
the HA cleavable by intracellular proteases (Banks et al., 2000; Donatelli et al., 2001; 
Rohm et al., 1995).  In nature, when low pathogenic avian influenza virus (LPAIV) 
strains are transmitted from avian reservoir hosts to highly susceptible poultry 
species, which then support several cycles of infection and replication, these strains 
may undergo a series of mutational events resulting not only in adaptation to their 
new hosts but also mutation into highly pathogenic forms (Banks et al., 2000; Perdue 
and Swayne, 2005; Rohm et al., 1995).  Although much attention has been focused on 
HPAI viruses, the importance of LPAI viruses can not be overlooked.  These viruses 
have major impact  not only with regard to the economic losses suffered by poultry 
producers (Halvorson, 2008) but  also because of the potential of LPAI viruses of the 
H5 and H7 subtypes to become HPAI viruses, breach  transmission barriers, and 
infect other species, including humans.  Expansion of host species range, with its 
implications for public health, make the understanding of mechanisms related to 
pathogenicity and host range restriction of AI viruses very important issues 
(Halvorson, 2008; Perkins and Swayne, 2003).  Combined pathology-based and 
molecular approaches, such as the one described here, will provide useful information 






4.3 Materials and Methods 
4.3.1 Viruses 
Low Pathogenic Avian Influenza Viruses: Two LPAI viruses were used in  
this study, referred to as WT and P22 AI viruses. The 
A/Mallard/Pennsylvania/12180/84  (H5N2) wild type (WT) virus was obtained from 
the repository at St. Jude Children’s Research Hospital, Memphis, TN, USA.  This 
virus was adapted by 22 serial passages of virus from lung in chickens that had been 
pre-exposed to IBDV, herein referred as P22 LPAI virus. 
 
The viruses were propagated in 10-day-old embryonated specific-pathogen-
free (SPF) chicken eggs and titrated to determine the 50% egg infectious dose  
(EID50) using the Reed and Muench method  (Reed, 1938). 
 
Infectious Bursal Disease virus (IBDV): IBD E-Delaware variant virus, 
prepared as described in 3.3.2.1, was used to infect 2-day-old SPF White Leghorn 
Chickens (Charles River Laboratories, Wilmington, MA, USA).  The IBDV-pre-
exposed chickens were housed for three weeks before inoculation with the WT or P22 
AI viruses. 
 
4.3.2 Animals and experimental infections 
To investigate the effect of adaptation in IBDV-pre-exposed chickens on the 
pathogenesis of the H5N2 LPAI virus, we evaluated histological changes after 




Leghorn chickens.   Four groups of nine 3-week-old chickens, including two groups 
of IBDV-pre-exposed and two groups of normal chickens, were infected with 108 
EID50 of either WT (one normal and one IBDV-pre-exposed group) or P22 (one 
normal and one IBDV-pre-exposed group) AI virus.  Two additional groups of 
chickens were used as controls: one group of IBDV-pre-exposed chickens and one of 
normal chickens that had been mock infected using PBS containing Antibiotic – 
Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO) as inoculum. 
 
Chickens were infected via ocular-nasal, intratracheal, and intracloacal routes 
with a total dose of 1 ml.  Tracheal and cloacal swabs were collected 1, 3, 5, and 7 
days post-infection (dpi) in buffered glycerol (1:1 glycerol, phosphate buffered saline 
with Antibiotic – Antimycotic solution (100X) (Sigma-Aldrich, St. Louis, MO)) and 
stored at -70° C until use.  The birds were observed and scored daily for clinical signs 
of disease.  Groups of three birds were euthanized and necropsied at 3, 5, and 7 dpi 
for macroscopic examination and collection of organs for histological analysis. 
 
4.3.3 Transmission Experiments with the P22 LPAI virus in normal and IBDV 
pre-exposed chickens 
To determine if viral replication and pathogenicity were related to improved 
transmissibility we evaluated transmission in normal and IBDV-pre-exposed chickens 
after infection with the P22 LPAI virus.   In order to do this, three IBDV-pre-exposed 
uninfected chickens were placed in direct, aerosol, and fecal contact with three 




studies were also conducted without IBDV-pre-exposure (normal chickens).  
Chickens one and three weeks of age were tested.  Throughout the experimental 
period, feed and water were provided ad libitum.  Tracheal and cloacal swabs were 
collected in buffered glycerol at 1, 3, 5, 7 and 9 dpi, inoculated in 10-day-old 
embryonated chicken eggs, incubated at 35o C, and tested by hemagglutination assay 
2 dpi. 
 
Animal experiments were carried out under BSL2+ conditions, with 
investigators wearing appropriate personal protective equipment, and were compliant 
with animal protocols approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Maryland, College Park, MD, USA and Animal 
Welfare Act (AWA) regulations. 
 
4.3.4 Histological examination 
To study differences in the pathogenesis of the H5N2 WT and P22 AI virus in 
chickens, a time-point evaluation of histological changes was conducted in tissues 
collected from groups of three chickens sacrificed systematically at 3, 5, and 7 dpi as 
described in 4.3.2.  Tissues, including lung, trachea, nasal sinus, conjunctiva, kidney, 
pancreas, spleen, liver, heart, thymus, intestine, brain, and bursa of Fabricius were 
collected and fixed in 10% buffered formalin followed by embedding in paraffin.  
Sections of 5 µm were prepared and stained with hematoxylin-eosin for microscopic 
examination.  Scoring of lesions was carried out by an avian pathologist, without 




mild; +,  moderate; +/-,  light; -, no lesions. A value from 1 to 4 was assigned 




AI viral antigen-positive cells were identified using an anti-avian influenza 
nucleoprotein (NP) monoclonal antibody (Synbiotics, Co.).  Sections of formalin-
fixed, paraffin-embedded tissue were incubated with a 1:150 dilution of the anti-NP 
monoclonal antibody overnight at 4 ºC.  Slides were then washed four times with 1X 
PBS and incubated at 37º C for 1 h with anti-mouse IgG peroxidase-conjugated 
antibody (Sigma-Aldrich, St. Louis, MO, USA) at a dilution of 1:200 according to the 
manufacturer’s recommendations.   Slides were then incubated for 10 min at room 
temperature with the substrate 3-amino-9-ethylcarbazole  (AEC) and counterstained 
with hematoxylin.  AI virus-positive cells were visualized under the microscope at 
magnifications of 20X, 40X and 100X. 
 
4.3.6 Virus sequencing 
Total RNA was extracted from allantoic fluid containing virus using the 
RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s 
instructions.   Reverse transcription was carried out with the Uni12 primer (5’ –
AGCAAAACGAAGG- 3’) and AMV reverse transcriptase (Promega, Madison, WI, 
USA).   Polymerase chain reaction (PCR) amplification was performed using 




specific primers.  The PCR products were sequenced using the Big Dye Terminator 
Protocol v3.1 (Applied Biosystems, Foster City, CA, USA).  Complete genome 
sequences, with the exception of regions recognized by the 5’- and 3’-end universal 
primers, were determined. 
 
4.4 Results 
The P22 H5N2 virus showed more efficient replication and caused clinical 
signs and severe lesions in the respiratory tract in IBDV-pre-exposed chickens.  
Results of previous experiments showed that passage of the mallard H5N2 LPAIV in 
IBDV-pre-exposed chickens resulted in efficient replication and suggested an 
increase in virus pathogenicity (Chapter 3).   We then wanted to determine if those 
changes would result in changes in the pathogenicity of the adapted virus in normal 
and IBDV-pre-exposed chickens compared to the WT virus; we addressed this by 
analyzing histological changes in a large group of tissues. 
 
4.4.1 Histological analysis confirmed the presence of pathological lesions 
primarily in the respiratory tract of P22 H5N2-infected chickens 
Based on clinical, virological, and macroscopic findings we observed a 
change in pathogenicity of the P22 H5N2 AI virus in this study.  In order to generate 
additional evidence in support of this finding, a time-point study was designed in 
which a comprehensive group of organs was analyzed by microscopy with the 
purpose of assessing the presence and severity of lesions.  The analysis showed that 




lesions primarily in the respiratory tract, with increased severity in IBDV-pre-
exposed, P22 AI virus-infected chickens.  Lungs were congested and edematous; 
areas of pneumonia were evident, primarily in the ventral region.  Histological 
analysis of the lungs of infected animals confirmed that the P22 AI virus caused 
significantly more severe pathology in chickens than the WT virus.  The P22 virus 
caused severe lesions in lung and trachea in 5/9 chickens and mild to moderate 
lesions in 4/9 normal infected chickens.   In contrast, the WT virus caused only mild 
to minimal lesions in lung; with the exception of one animal that had minimal lesions 
in the trachea the other tissues were normal (Figure 4).  The severity of lesions caused 
by the P22 virus in IBDV-pre-exposed chickens was also greater in lung and trachea, 
varying from severe to moderate in comparison to lesions seen in animals infected 
with the WT virus, which caused mild to minimal lesions in the same organs (Figure 
5).  
 
The P22 virus caused lesions in organs other than the respiratory tract, 
including the kidney, pancreas, liver, thymus, and heart while the WT virus caused 
minimal or no lesions in these organs in either normal or IBDV-pre-exposed infected 
chickens (Figure 4, Figure 5, Figure 6).  Taken together, our results show that IBDV-
pre-exposure influences the severity of lesions caused by AI, particularly in 


















Figure 4. Histological lesions in normal chicken infected with the WT and 
P22 chicken-adapted H5N2 virus. Groups of nine chickens were inoculated 
with 108 EID50/ml of the H5N2 AIV. Tissue samples collected from groups of 
birds (3/group) at 3, 5, and 7 dpi. A value of 1 to 4 was assigned according to 
severity of lesions as follows: 4: Severe; 3: moderate; 2: mild; 1: minimal; 0.2: 




































Figure 5. Histological lesions in IBDV-pre-exposed chicken infected with the WT 
and P22 chicken-adapted H5N2 virus. Groups of nine chickens were inoculated with 
108 EID50/ml of the H5N2 AIV. Tissue samples collected from groups of birds 
(3/group) at 3, 5, and 7 dpi. A value of 1 to 4 was assigned according to severity of 
lesions as follows: 4: severe; 3: moderate; 2: mild; 1: minimal; 0.2: no lesions. Each 









4.4.2 Viral antigen was identified primarily in inflammatory infiltrates in lungs 
of infected chickens 
Consistent with the knowledge that monocytes and macrophages are fully 
susceptible to influenza A virus infection in mammals (La Gruta et al., 2007; Perrone 
et al., 2008) we found that P22 H5N2 virus causes a severe infiltration of 
inflammatory cells in the respiratory tract of infected chickens.  
Immunohistochemical analysis demonstrated the presence of viral antigen in the 
respiratory tract, particularly in inflammatory infiltrates and most likely in 
macrophages, in the lungs of infected chickens (Figure 7).  Viral antigen was also 
detected in the spleen, kidneys, and occasionally in the liver (Figure 7). These 
findings are consistent with the results of the histological analysis. 
  
4.4.3 Increased pathogenicity and severity of lesions are not sufficient for 
efficient transmission of the P22 H5N2 virus in chickens 
We wanted to determine if the increase in virus replication and severity of 
lesions caused by the P22 H5N2 virus was associated with efficiency of transmission. 
We were also interested in exploring whether the age of the birds would influence the 
results. To address these issues we determined transmissibility in normal and IBDV-




























Figure 7. Detection of AI-viral antigen-positive cells.  H5N2 P22 AIV antigen 
positive reaction is evident in the lung (Panel A), upper respiratory tract (Panel B), 
kidney (Panel C) and spleen (Panel D) of chickens 3 dpi with the P22 LPAI virus. 
Images show immunohistochemical detection using anti-avian influenza 
nucleoprotein (NP) monoclonal antibody as primary antibody, immunoperoxidase 













Virus was isolated from tracheal swabs up to 7 dpi in the groups of one- and 
three-week-old IBDV-pre-exposed chicken.  It is important to note that, in the three-
week-old IBDV-pre-exposed infected chickens, two out of three animals showed 
respiratory symptoms and died at 6 and 7 dpi; the experiment was repeated once with 
similar results.  At necropsy, macroscopic findings included severe airsacculitis and 
pneumonic lesions; despite these findings, virus was not detected in tracheal or 
cloacal swabs from the contact animals (Table 4). 
 
When the same approach was carried out in normal chickens, virus was 
isolated from tracheal and cloacal swabs in 3-week-old infected chickens up to 3 dpi. 
The animals appeared clinically normal and virus was isolated from tracheal swabs in 
one out of three contact animals at 3 dpi.  In 2-day-old normal chickens the virus was 
isolated from tracheal and cloacal swabs up to 7 dpi in infected chickens.  In this 
experiment two out of three chickens died at 5 and 6 dpi and the virus was isolated 
from tracheal swabs in one out of three contact animals at 5 dpi.  When 1-week-old 
normal chickens were infected with the same virus, the virus was isolated from 
tracheal and cloacal swabs up to 3 dpi only in infected chickens and there was no 
transmission to contact birds (Table 5). 
 
4.4.4 Amino acid substitutions occurred in the surface glycoproteins of the 
LPAIV H5N2 during passage of the virus in IBDV-pre-exposed chickens 
Due to an increase in pathogenicity observed in our study and knowing that 
surface glycoproteins play a role in the pathogenicity of avian influenza viruses 






Table 4. Replication – Transmission studies of P22 chicken-adapted H5N2 AI virus 
in IBDV pre-exposed chickens 
 
 
1No cloacal route of inoculation 













 No. positive chickens /total No. of  chicke n s  






Group  Trache a  Cloaca  Trache a  Cloaca  Trache a  Cloaca  
Infecte d  3 / 3  3 / 3  3 / 3  0 / 3  1 / 3  0 / 3  1 week  
Contact 0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  
Infected  3 / 3  3 / 3  2 / 3  2 / 3  0 / 1  1 / 1  3 weeks 
Contact 0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  
Infected  3 / 3  0 / 3  3 / 3  0 / 3  0 / 1  0 / 1  3 weeks1  








Table 5. Replication – Transmission studies of P22 chicken-adapted H5N2 AI virus 






















No. positive chickens /total No. of  chicke n s  






Group  Trache a  Cloaca  Trache a  Cloaca  Trache a  Cloaca  
Infected*   3 / 3  2 / 3  2 / 2  1 / 2  2 / 2  1 / 2  2 days  
Contact 0 / 3  0 / 3  1 / 3  0 / 3  0 / 3  0 / 3  
Infecte d  3 / 3  3 / 3  0 / 3  0 / 3  0 / 3  0 / 3  1 week 
Contact 0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  0 / 3  
Infected  3 / 3  3 / 3  0 / 3  0 / 3  0 / 3  0 / 3  3 weeks  





the glycoproteins HA and NA that allowed the mallard H5N2 virus to become better 
adapted to chickens.  The H5 and H7 subtypes of AI have the potential to mutate into 
highly virulent strains by different mechanisms.  One mechanism involves mutations 
in the amino acid sequence of the surface glycoproteins; e.g., a single amino acid 
mutation in HA of the H5N2 virus was identified in virus responsible for an epidemic 
in 1993 in the USA (Silvano et al., 1997). Others have shown that point mutations 
affecting glycosylation sites in HA have been associated with regulation of virulence 
(Deshpande et al., 1987).  We looked for these types of modifications by comparing 
deduced amino acid sequences from the complete open reading frames of the WT and 
P22 virus genomes.  Comparative sequence analysis revealed several amino acid 
substitutions, which occurred primarily in HA; only one substitution was identified in 
NA (Table 6).  None of the changes occurred in the HA cleavage site and there were 
no apparent changes in the glycosylation sites.  The HA gene of the P22 virus differed 
from that of the WT virus in HA1 region at positions 24, 77, 118, 158, 216, and 230 
(H3 numbering).  In the HA2 region the P22 virus differed from the WT virus at 
position 106, 139, and 183 (H3 numbering).  Based on examination of GenBank 
sequences, all amino acid substitutions identified in our analysis have been identified 
in at least one other strain of influenza A viruses from birds or in the H5N1 influenza 
virus isolated from humans in Asia.  The one exception is the N77D amino acid 
substitution, which has not been previously identified.  The E24K mutation is found 
primarily in chicken virus; interestingly, this amino acid substitution is present in 






Table 6. Amino acid substitutions in the genome of the mallard H5N2 AIV after 











HA1* 24 E K 
 77 D N 
 118 F L 
 158 N D 
 216 E V 
 230 M I 
HA2 106 R I 
 139 E K 
 183 T I 
NA 370 S L 
PB2 624 A K 
PB1 59 T I 
NP 105 V M 
 373 S F 
 377 N S 
 402 S F 
M 93 M I 
NS1 166 M I 






circulated in 1983.  The F118L substitution is found in a H5 virus from Guatemala in 
2003.  The N158D mutation is present in avian viruses from North America and, 
more frequently, in viruses from Asia, as well as in H5N1 virus isolated from 
humans.  The amino acid substitution E228V is found in chicken viruses from Texas  
in 2002 and 2004.  The M230I mutation has been identified in virus from chicken and 
other birds.   Regarding changes in the HA2 region, R106I is found in a turkey H5N2 
virus and the T183I mutation is found in chicken, other birds, and several H5N1 
viruses from Asia.  Interestingly, the E139K mutation is found only in a H5N1 virus 
isolated from humans.  
 
A single amino acid substitution was observed in the NA protein at position 
370 (S370L).  This position is in a region that determines specific activity (Kobasa et 
al., 2001); previous studies have shown that individual amino acid mutations at 
residue 370 lead to increased NA activity (Kobasa et al., 2001).  This amino acid is 
highly conserved among avian influenza viruses (Ser370).  Interestingly, a Ser370Leu 
substitution was found in the NA protein of the P22 H5N2 virus and a Leu is present 
in this position in the human virus A/Ann Arbor/6/60.  Position 370, as well as 
positions 367 and 400, is also important for NA hemadsorption activity.  This is a 
characteristic of all NA subtypes in avian viruses but has been lost in human virus 





Comparison of the complete genome sequences of the H5N2 WT and P22 
adapted viruses showed amino acid substitutions in internal genes (Table 6).  We 
found two amino acid substitutions in the M1 protein at positions 93 and 121.  The 
change in amino acid 121 (T121A) is located in a position that is considered specific 
for either avian or human influenza strains (Buckler-White et al., 1986).  This is one 
of three sites that possibly define an avian or human class of M1 protein, which are 
clustered within the center of the molecule at residues 115, 121, and 137 (Buckler-
White et al., 1986).  
 
There were no significant amino acid changes in the polymerase genes; the 
PA gene was unchanged; there was a single amino acid substitution in position 624 in 
the PB2 gene and one in position 59 of the PB1 gene. 
 
Two amino acid substitutions were identified in the NS1 protein; one was in 
position 166 and the other in position 183.  The NP protein showed amino acid 
substitutions in positions 105, 373, 377, and 402.  
 
The implications of these kinds of changes for the adaptation and/or 
pathogenicity of influenza viruses will require further study. 
 
4.5 Discussion 
It has been shown that there is a relationship between the virulence of avian 




al., 1995).  It has also been suggested that the pattern of disease will vary with the 
virulence of the avian influenza virus and the resistance of the host (Hooper et al., 
1995). Comparing the replication efficiency of the H5N2 WT and P22 LPAI viruses 
in normal and IBDV-pre-exposed chickens we found that, in contrast to previous 
studies showing a general predilection of nonpathogenic or low-pathogenic duck 
viruses to replicate in kidney and digestive tract tissues in chickens (Condobery and 
Slemons, 1992), the H5N2 LPAIV investigated in this study showed a predilection to 
replicate in the respiratory  tract; this is consistent with data on influenza virus 
infection in mammals (Neumann and Kawaoka, 2006). 
 
The results of these experiments indicate that, under the conditions of this 
study, IBD-pre-exposure favors adaptation and plays a role in the pathogenesis of AI 
in poultry.  The replication efficiency, and the severity of gross and microscopic 
lesions, increased for the WT virus used in this study after passage of the H5N2 
LPAIV in IBDV-pre-exposed chickens.  According to virus titers found in tracheal 
swabs and tissues (primarily lung) following inoculation via natural routes, passage of 
the H5N2 LPAIV in IBDV-pre-exposed chickens apparently favors replication in 
normal as well as in IBDV-pre-exposed birds and, based on the number and severity 
of macroscopic and microscopic lesions, increases pathogenicity of the AIV in IBD- 
pre-exposed chickens.  These properties are indicative of a virus that has been 
selected for during the adaptation process.  As a result, the virus is a better fit than the 






Evidence of viral antigen in inflammatory cells is significant because these 
cells are involved in the host response to clear the infection but they can also 
contribute to aggravating the clinical outcome of the lung infection.  This situation 
could be occurring in IBDV-pre-exposed chickens infected with the P22 H5N2 virus, 
where we observed a more severe inflammatory response in addition to the 
respiratory signs. 
 
 We found differences in viral replication between groups, with all infected 
animals shedding virus in trachea and/or cloaca.  There was a remarkable difference 
in clinical signs after P22 infection in three-week-old IBDV-pre-exposed chickens 
compared to normal chickens; two out of three birds died after infection with the P22 
AI virus and there was no transmission to contact birds in this group.  Interestingly, 
the three-week-old normal chickens did not show clinical signs, while younger birds 
did and transmission of AIV to contact birds occurred only sporadically in the normal 
group.  These results confirm that factors other than pathogenicity and level of virus 
shedding are involved in transmission of influenza virus in chickens.  It will be 
interesting to determine the role of age in the susceptibility to AI infection in 
chickens. 
 
Passage of the mallard H5N2 AI virus in IBDV-pre-exposed chickens resulted 
in changes at the molecular level, particularly in the surface glycoproteins and most 




between the HA1 and HA2 regions agrees with the proportion of changes occurring 
during evolution of influenza virus in nature, where change usually occurs at a three-
fold higher rate in the HA1 region than in HA2.  This difference could be the result of 
different immune pressures (Nakajima et al., 2003). 
 
Our results suggest that amino acid substitutions such as those identified in 
this study might contribute to favoring replication of the H5N2 virus in chickens.  
Changes such as the one at position 158, located near the receptor binding site, have 
been implicated in changes in receptor-binding affinity as a result of differences in 
oligosaccharide interactions, which could potentially have an effect on the host or 
cells within the host that are prone to infection by the virus (Ha et al., 2002).   
 
Arginine, a basic amino acid, was replaced in the WT virus by the non-polar 
aliphatic amino acid, isoleucine, in the P22 virus at position 106 of the HA2 region. 
Whether this change will have an effect on ionization during cleavage of the 
precursor HA0 at low pH is not known (Ha et al., 2002).  A solvent-restricted site 
occurs in the structure of the H5 HA near the fusion peptide and the HA2 position 
106 amino acid is located in this area (Ha et al., 2002).  Furthermore, the amino acid 
located at position 106 is one of the residues implicated in the low-pH-induced 
refolding of HA that is required for membrane fusion. 
 
The NA stalk region, where a deletion has been identified in some H5N1 




2005) remained intact in the P22 chicken adapted AI virus.  However, a single amino 
acid substitution in the NA glycoprotein occurred in a region that is highly conserved 
among avian influenza viruses, acquiring an amino acid that is present in a human 
influenza virus.  The potential contribution of this change to the generation of the new 
virus phenotype needs to be determined.   
 
Although it is generally accepted that changes in the glycoprotein HA 
contribute preferentially to increased virulence, it is clear that the virulence of 
influenza virus is polygenic and that other, non-genetic factors are involved.  
Additional studies will be necessary to determine the contribution of the changes in 
amino acid residues to the virulence of AI virus in chickens and to establish their role 
in the adaptation and/or pathogenesis of H5 virus in land-based birds. 
 
Understanding the molecular changes that occur during adaptation of 
influenza A virus to a new host will provide important insight into the requirements 
for productive viral replication and cross-species transmission.  The results presented 
here show that pre-existing conditions, such as pre-exposure to IBDV, contribute to 
the mechanism of adaptation and generation of new, more highly pathogenic viruses 








Chapter 5: Exacerbation of clinical signs and altered host responses 
to low pathogenic H5N2 avian influenza virus in chickens previously 
exposed to infectious bursal disease virus 
 
5.1Abstract 
We investigated the effects of viral-induced immunosuppresion in chickens 
and their susceptibility, disease progression and host molecular responses against 
infection with a H5N2 low pathogenic influenza virus (LPAI). Infectious bursal 
disease virus (IBDV) is a powerful immunosuppressive pathogen that preferentially 
infects and destroys B-cells.  Prior exposure to IBDV lead to increased susceptibility 
to infections with a mallard H5N2 LPAI virus compared to normal chickens, although 
the infection did not cause overt signs of disease in either group.  The increased 
susceptibility to the mallard H5N2 LPAI virus allowed us to further adapt the virus to 
chickens.  After 22 passages (P22) in IBDV-pre-exposed chickens, a LPAI virus was 
obtained that replicated substantially better than the WT mallard virus in both IBDV-
pre-exposed and normal chickens. Interestingly, the P22 virus showed similar levels 
of replication in the respiratory and intestinal tracts of both groups although it caused 
exacerbated signs of disease and excess mortality in the IBDV-pre-exposed group.  
Thus, we investigated if the expanded tissue tropism or altered local gene expression 
were associated with the different disease outcome.  We suggest that prior IBDV 
exposure provides a port of entry for avian influenza in an otherwise resistant chicken 
population.  Furthermore, adaptation of AI in IBDV-pre-exposed chickens may allow 




brain.  We also demonstrate that IBDV-pre-exposed chickens show less than optimal 
humoral responses to LPAI infection and altered local molecular pathways that 
eventually lead to an exacerbated disease and death.  These findings are particularly 
important when considering vaccination campaigns against IBDV and AI. 
 
5.2 Introduction 
Influenza A virus infections have been responsible for important disease 
outbreaks in birds, livestock, and wildlife (Perdue and Swayne, 2005). Introduction of 
avian influenza virus (AI) into poultry species is usually associated with outbreaks of 
varying intensities (Kwon et al., 2008). Most influenza virus infections are sub-
clinical in poultry, producing only mild to moderate signs of disease.  These AI 
viruses have been categorized as low pathogenic (LPAI) or mildly pathogenic 
(MPAI).  AI strains that cause severe systemic disease, associated with high 
morbidity and mortality, are known as highly pathogenic AI viruses (HPAI).   
 
The factors that determine virulence and interspecies transmission of 
influenza viruses are still poorly understood.  The likelihood of a virus becoming 
endemic in a new host (recipient species) depends on two major factors: at the macro 
level, the interaction between donor and recipient animal species, and at the 
molecular level, the intricate interactions between the host and virus components 
(Kuiken et al., 2006).  A wealth of knowledge exists with respect to the molecular 
markers of virulence of influenza viruses; thus, virulence is considered a polygenic 




accumulation of basic amino acids at the cleavage site of the HA protein is a hallmark 
of the generation of AI with high pathogenic potential.  Only AI viruses of the H5 and 
H7 subtypes have shown the potential to become highly pathogenic (Ito et al., 2001; 
Rott et al., 1976; van der Goot et al., 2003). There is also evidence that the internal 
components of the virus including the RNA polymerase complex (PB2, PB1, PA), 
nucleoprotein (NP), matrix protein (M1, M2), and nonstructural proteins (NS1, 
NS2/NEP) also contribute to the host range, although little is known with respect to 
the role of these components for interspecies transmission of AI viruses among birds 
(Wasilenko et al., 2008). 
 
Much less is known regarding the host’s immune status as a potential 
facilitator in the cross-species transmission and virulence of AI (Swayne, 1997). 
Despite substantial differences among birds and mammals, effective elimination of 
AI viruses require a functional immune system. The nature of the host response to AI 
in birds is largely unknown.  Any compromising conditions such as 
immunosuppression could enhance disease susceptibility to AI.  In this regard, 
infectious bursal disease virus (IBDV) constitutes a major economic threat to the 
poultry industry because it adversely affects the immune status of poultry. IBDV is a 
RNA virus that causes severe immunosuppression.  The immunosuppression is 
mostly at the humoral level due to the virus’s preferential site of infection, the B cells 
in the Bursa of Fabricius (Kim et al., 1999; Saif, 1991; Withers et al., 2005). More 
importantly, IBDV live attenuated vaccines are used throughout the world, many of 




In this study, we investigated the effects of prior IBDV exposure on disease 
susceptibility or pathogenesis to infection with a LPAI H5N2 strain.  Our results 
indicate that IBDV-induced immunosuppression exacerbates AI-induced 
pathogenicity and a prior IBDV exposure leads to a defective humoral immune 
response against LPAI virus in chickens.  Microarray gene expression analysis 
revealed that IBDV-pre-exposed chickens show higher expression of genes associated 
with local inflammatory responses and cell death following AI infection compared to 
normal chickens. 
 
5.3 Materials and Methods 
5.3.1 Viruses 
The A/Mallard/Pennsylvania/12180/84 (H5N2) virus was adapted by serial 
lung passages (22 times, herein referred as P22) in chickens previously exposed to 
IBDV.  The P22 H5N2 chicken-adapted influenza virus was propagated in 10-day old 
embryonated chicken eggs and titrated by egg infectious dose 50 (EID50) using the 
Reed and Muench method (Reed, 1938).  The IBDV E-Delaware variant virus was 
used to induce immunosuppression in chickens. Specific-pathogen-free (SPF) White 
Leghorn chickens (3-week old, Charles River Laboratories) were infected with IBDV 
and bursas were collected 48 hours post-infection (hpi) and homogenized to prepare 
virus stocks. The chicken infectious dose 50 (CID50) of the IBDV in bursa 




5.3.2 Animals and experimental infections 
Two-day old SPF chickens were infected with 100 CID50 of the E-Del IBDV 
strain by the oral and ocular routes to induce immunosuppression.  Two to 4 weeks 
later, normal and IBDV-pre-exposed chickens were separated into groups of 3 and 
infected with either 5 x 106 EID50 or 1 x 108 EID50 of the P22 H5N2 LPAI virus as 
indicated. Chickens were infected via the oculo-nasal, intra-tracheal and intra-cloacal 
routes with 1 ml of AI virus inoculum. Mock-infected chickens were used as controls. 
Tracheal and cloacal swabs were collected at 1 and 3 days post-infection (dpi) in 
buffered glycerol (1:1 glycerol, phosphate buffered saline with Antibiotic -
Antimycotic solution (100X), Sigma-Aldrich, St. Louis, MO) and stored at -70° C 
until use.  Birds were euthanized and necropsied at 3 dpi. Homogenates from lungs 
were prepared in brain heart infusion medium (BHI), and stored at -70° C until use. 
To determine the chicken infectious dose 50 (CID50) of the WT and P22 virus, groups 
of 3 SPF White Leghorn chickens (3-week old) were infected with serial ten fold 
dilutions of the virus and lungs were collected at 72 hpi and homogenized to 
determine presence of virus. Swabs samples and tissue homogenates were titrated for 
virus by the Reed and Muench method (Reed, 1938).  Undiluted samples that were 
positive for hemagglutination but did not show hemagglutination at the 10-1 dilution 
in EID50 assays were scored as positive with the notation of “<1.0 EID50/ml.” The 
birds were observed and scored daily for clinical signs of disease. Experiments were 
carried out under BSL2+ conditions with chickens housed in isolators under negative 
air pressure. Investigators wore appropriate protective equipment.  All experiments 




Use Committee of the University of Maryland, College Park and under the Animal 
Welfare Act. Throughout the experimental period, feed and water were provided ad 
libitum. 
 
5.3.3 Antibody determination 
Serum samples collected from chickens after P22 H5N2 infection were tested 
for the presence of H5 AI and IBDV antibodies by ELISA tests. Commercially 
available, USDA licensed antibody test kits for the detection of antibodies to AI virus 
(Avian Influenza Virus Antibody Test Kit, ProFLOKPlus®, Synbiotics Co., San 
Diego, CA) and infectious bursal disease virus (Infectious Bursal Disease Virus 
Antibody Test Kit, ProFLOKPlus®, Synbiotics Co., San Diego, CA) were used 
following the manufacturer’s recommendations. In addition, hemagglutination 
inhibition (HI) tests (following WHO recommendations) were performed using serum 
samples collected at 14 dpi to detect the presence of antibodies against H5 AI. Before 
HI test, serum samples were pretreated with receptor-destroying enzyme as 
recommended by the World Health Organization (WHO). 
 
5.3.4 Microarray analysis 
Gene expression analysis was carried out as described (Kim, 2008). Total 
RNA was isolated from tissues collected at 3 dpi using TRIzol (Invitrogen®, 
Carlsbad, CA), treated with Turbo DNase (Ambion®, Austin, TX), and then purified 




manufacturer’s protocols.  The concentration and purity were determined using a 
spectrophotometer. RNA quality was examined by 28S and 18S RNA band 
visualization following gel electrophoresis and ethidium bromide staining.  Total 
RNA (3 µg) was used to generate Alexa Fluor 555 or Alexa Fluor 647 (Invitrogen) 
labeled aRNA probes. Amplified amino allyl RNA synthesis, dye coupling, and 
labeled aRNA purification were performed using the Amino Allyl Message Amp II 
aRNA Amplification Kit according to the manufacturer’s instruction (Ambion, 
Austin, TX).  Labeled aRNA (15 µg) from each infected group or uninfected control 
was used for hybridization to compare the uninfected vs. the infected by a reference 
design (i.e. control vs. WT, control vs. P22, control vs. IBDV, control vs. IBDV-WT, 
and control vs. IBDV-P22).  The 10K element AVIELA microarray was constructed 
as previously described (Kim, 2008). All hybridizations were performed twice to 
make a technical replicate and control RNA from uninfected chicken was used as 
reference RNA (Dobbin et al., 2003).  Hybridization was performed as following; 
washing with 1% SDS in 3X SSC (1X SSC is .015 M NaCl plus 0.015 M sodium 
citrate) at 40~50°C for 5 minutes with moderate agitation, washing 3 times with 
distilled water at 40~50°C for 5 minutes with mild agitation, boiling at 100°C for 3 
min and then chilled in ice-cold 100% ethanol, and centrifuging at 1,000 rpm for 2 
min to dry in capped 50 ml centrifuge tubes.  For two-color hybridization, the aRNAs 
were incubated at 60°C for 10 min with HybIt hybridization buffer (Telechem 
International, Sunnyvale, CA) and aRNAs were applied to pre-warmed microarray 
slides and incubated at 50°C in a Hybridization Cassette Plus (Telechem) overnight.  




0.06X SSC plus 0.01% SDS, 0.06X SSC, and 0.01X SSC buffers with moderate 
stirring using a High-Throughput Wash Station (Telechem), followed by 
centrifugation at 1,000 rpm for 2 min to dry slides. 
 
Microarray images were acquired by laser confocal scanning using a 
ScanArray Lite microarray analysis system (Perkin-Elmer, Boston, MA) at a 
resolution of 10 µm. A 16-bit TIFF image was generated for each channel (Alexa 
Fluor 555 and Alexa Fluor 647).  The scanned microarray images for each channel 
were overlaid and quantified to determine the fluorescent intensities of the two dyes 
for each spot by using the ScanArray Express analysis software version 3.0 (Perkin-
Elmer). Spots were detected using an adaptive circle algorithm in QuantArray 
program and all spots were visually examined (Szretter et al., 2007).  
 
The MIDAS 2.19 software of TM4 microarray analysis package 
(http://www.tigr.org) was used to produce qualified and normalized array data. 
Briefly, each median spot intensity (Alexa Fluor 555 or Alexa Fluor 647) was 
determined by subtracting the median local background from median signal intensity 
values, and then flag information was applied to filter bad spots. One bad channel 
tolerance policy was stringent and signal to noise threshold was 2.  Two-step 
normalization was performed (Sioson et al., 2006); total intensity and block 
LOWESS (locally-weighted regression and smoothing scatter plots) method, 
followed by standard deviation (SD) regularization of block and slide SDs. The 




software (Silicon Genetics, Redwood, CA) for statistical and fold change analyses. To 
generate Ch2/Ch1 intensity ratios, signal channel values (infected group, Ch2) were 
divided by control channel values (control group, Ch1).  The elements that were 
modulated >2 fold change with statistical significance (p < 0.05) were filtered using 
Volcano plot method (Jin et al., 2001). 
 
5.3.5 Bioinformatic analysis 
All data files including DNA sequences and Gene Ontology (GO) data were 
obtained from NCBI (http://www.ncbi.nlm.nih.gov).  Avian IEL cDNA sequences on 
the AVIELA chip were identified against reference RNA and protein sequences 
(formatted database for Blast, Dec. 2007) using the stand-alone Blast program 
(version 2.2.13).  The acceptance criteria of Blast results were alignment length ≥ 100 
nucleotides and e-value ≤ 1e-100 for DNA and alignment length ≥ 30 amino acids and 
e-value ≤ 1e-10 for protein.  Entrez gene and Homologene data (Dec. 2007) from 
NCBI were used to gather gene information (identification number, symbol, name).  
GO annotations were extracted from GO data of Entrez gene in NCBI.  Statistical and 
narrow-down analyses of GO mappings were performed using a stand-alone EASE 
(Expression Analysis Systematic Explorer) program and the criteria for acceptance 
was ≥ 2 genes with FDR < 0.1 at level 4 of biological processes of GO (Hosack et al., 
2003).  Python (version 2.2.4) and SQL scripts were used to process and manipulate 




5.3.6 Real Time PCR validation 
Total RNA was prepared as described above and cDNA synthesized using the 
Transcriptor First Strand cDNA Synthesis kit (Roche®) according to the 
manufacturer's instructions. Primers for real-time analysis were designed based on 
Genbank sequences using Oligo Perfect Primer software (Invitrogen®) (Table 7). 
Real-time PCR was performed using SYBR Green I Master (Roche®) and was 
normalized to the GAPDH housekeeping gene. The results were run on a 480 light 
cycler RT PCR machine (Roche®). Data analysis was carried out using relative 




5.4.1 Chicken-adapted H5N2 P22 influenza virus replicates at similar levels in 
the respiratory tract of normal and IBDV-pre-exposed chickens 
Previous studies in our laboratory showed that prior exposure of chickens to 
IBDV early in their life (2-day old) increases their susceptibility to AI (Chapter 3). 
This increased susceptibility to AI virus allowed us to adapt an H5N2 influenza virus 
isolated from a mallard, A/mallard/Pennsylvania/84 (H5N2) virus, in IBDV-pre-
exposed chickens.  After 22 serial lung passages in IBDV-pre-exposed chickens, we 
obtained a mutant H5N2 virus (P22) which replicated better in IBDV-pre-exposed 
and normal chickens than the WT H5N2 mallard virus (Fig 8). The WT mallard 




Table 7.  Primers used in Relative Quantitative Real Time RT-PCR 
Gene 
symb o l  
Gen Bank 
Accession No. 
Forwa r d  Reverse 
CCL4  NM_00103036 0  5’-GTTCATCACCAGGAAGGGC-3’ 5’-TGGCAGGGCCTGCAAGTGG-3’ 
CD3d  NM_20551 2  5’-CCTGCAATGTCAAGAAAGCA-3’ 5’-GCCTCTGGGATCATCGTAAA-3’ 
B2M  NM_00100175 0  5’-GCAGGTGTACTCCCGCTTCC-3’ 5’-CCCACTTGTAGACCTGCGG-3’ 
IFI35  XM_41813 2  5’-GCTGCAAAAGGACAAGGAAG-3’ 5’-TGGAGGGACACCTTTTCATC-3’ 
NK-lysin NM_00104468 0  5’-GATGGTTCAGCTGCGTGGGATGC-3’ 5’-CTGCCGGAGCTTCTTCAACA-3’ 
TAP XM_42530 2  5’-CAGGGAAGAGCACTCTGGTG-3’ 5’-GCACAGGTAGGAGTGCTGGT-3’ 
CREB3  XM_42499 0  5’-GCTGGGTCCTGCTCTTACTG-3’ 5’-CATGCACAGCTTGGAAAGAA-3’ 
 1 
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Figure 8. Replication of H5N2 AI virus in the respiratory tract of chickens.  Normal 
and IBDV-pre-exposed chickens (3/group) were inoculated with H5N2 virus P22 and 
WT.  Lung homogenates and tracheal swabs collected at 3 dpi were inoculated into 
embryonated chicken eggs and titrated by EID50. Each bar shows the average titer per 
group. A, B, C and D show results after inoculation with 1X108 EID50 of the WT or 
the P22 virus. A) and B) show the results of titers in trachea and lung in IBDV-pre-
exposed chickens, respectively. C) and D) show the results of titers in trachea and 
lung in normal non-exposed chickens. E) and F) show results of virus shedding in 
trachea and virus replication in lung of normal chickens after inoculation with 5X106 
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in vitro, and molecular analysis revealed that the P22 virus was, like its parental 
strain, a LPAI virus (Chapter 4).  In order to better understand the effects of IBDV-
pre-exposure on the susceptibility to the P22 LPAI virus, we compared the P22 and 
WT H5N2 virus infections in normal and IBDV-pre-exposed chickens infected with 1 
x 108 EID50 of virus inoculum.  Initial analysis using tracheal swabs and lung 
homogenates prepared at 3 dpi showed that the P22 virus replicates better than the 
WT mallard H5N2 virus in normal and IBDV-pre-exposed chickens (Fig 8); however, 
no statistical differences were observed in the amount of P22 virus shedding between 
the normal and IBDV-pre-exposed chickens.  In contrast, the WT mallard H5N2 virus 
showed slightly better replication in IBDV-pre-exposed than in normal chickens (Fig 
8).  The improved adaptation of the P22 virus for chickens was better appreciated 
when a lower dose of virus was used: Normal chickens infected with 5 x 106 EID50 of 
the WT virus showed no virus shedding at 3 dpi from either the trachea or the lungs 
(Fig 8 E and F).  In contrast, the same dose of P22 virus yielded an average of 
approximately 6 log10 EID50 of virus, a ~1 million fold improvement compared to the 
WT virus (Fig 8 E and F).  The results are also consistent when CID50 were calculated 
for both viruses, indicating that adaptation of a LPAI virus in IBDV-pre-exposed 
chickens can indeed select for a strain better adapted for immunocompetent chickens 
(Table 8).  These results suggest that IBDV-induced immunosuppression of birds 
provides an environment for the adaptation of mallard AI viruses; as a result these 
adapted viruses have the potential to infect immunocompetent poultry. 
 
 





Table 8. CID50 for WT and P22 H5N2 AI viruses 
 
 
Virus  Log10 CID50/ m l  
Log10 EID50/ml/ 
Log10 CID50/ m l  
WT  2 . 5  6 . 5  
P 2 2  6 . 0  3 . 2  
 1 
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5.4.2 Previous IBDV exposure and the opportunity for LPAI brain tissue 
tropism.   
We examined whether the P22 virus show altered tissue tropism in IBDV-
exposed chickens compared to normal chickens.  At 3 dpi, we determined virus titers 
in the respiratory and intestinal tracts, and in the brain (Fig 9).  Several important 
observations were made after examining the tissue tropism of the P22 H5N2 virus: 1) 
Previous IBDV exposure resulted in both the P22 and WT viruses to be consistently 
isolated from the brain of infected chickens. To our knowledge, this is a novel feature 
of LPAI infections in chickens, and suggests that previous IBDV exposure may 
provide an opportunity for LPAI viruses to change their phenotype, tissue tropism or 
become better adapted to poultry, 2) Viremia was also occasionally observed in 
IBDV-pre-exposed chickens. Viremia was observed in 8 out of 33 chickens during 
the adaptation of the H5N2 LPAI virus in IBDV-pre-exposed chickens. This finding 
suggests that previous IBDV exposure allows the virus to reach organs that would 
normally not be affected in a LPAI infection, and 3) The P22 virus was consistently 
isolated from the respiratory and intestinal tracts and the brain in normal chickens. 
This is an indication that P22 LPAI extended its tissue tropism in an immune 
competent host.  Our studies also suggest that the P22 virus replicated better in 
IBDV-pre-exposed and normal chickens than the WT H5N2 virus.  More importantly, 
except for the presence of viremia in the IBDV-P22 group, the amount of P22 virus 
produced in the lungs and virus shedding in trachea was similar between the IBDV-









            
Figure 9. Replication of H5N2 AI virus in 3-week-old SPF chickens. Samples 
collected from groups of birds (3/group) at 3 days after inoculation of the P22 or WT 
viruses.  Titration performed in inoculated embryonated chicken eggs by EID50.  Each 
bar shows the average titer for each group of 3 chickens. Figure A shows results in 
IBDV-pre-exposed chickens. Figure B shows results in normal chickens. 
*(Represents average of 2 positive chickens) 
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5.4.3 Previous IBDV exposure leads to a defective humoral immune response 
against LPAI 
As expected from our initial studies, a constant finding was atrophy of the 
bursa of Fabricius in IBDV-exposed chickens (Chapter 3).  Thus it was not surprising 
that these chickens would have a defective humoral immune response.  In order to 
test the early humoral response to LPAI, IBDV-pre-exposed and normal chickens 
were challenged at 3 weeks of age (3 weeks post IBDV infection) with the P22 virus. 
At 0, 3, 5, and 7 dpi, blood samples were collected for IBDV and AI antibody titers. 
ELISA tests showed an antibody response to IBDV in the IBDV-infected group but 
not in the normal group (Table 9).  In contrast, only the normal chicken group, not the 
IBDV-exposed group, showed positive antibody response against AI virus by ELISA 
and HI assays. Chickens of 1 and 3 weeks of age either naïve or previously infected 
with IBDV were challenged with the P22 virus and serum samples collected at 14 dpi 
(Table 10).  Naïve animals seroconverted after P22 H5N2 LPAI virus infection, 
showing higher levels of antibodies than the chickens that were previously exposed to 
IBDV. These results suggest that infection with LPAI in chickens previously exposed 
to IBDV may result in a delayed or impaired humoral response.  This observation has 
profound implications when considering vaccination to control the spread of AI and 
suggests that a poor humoral response in immunocompromised hosts could contribute 
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Three-week-old chickens were inoculated with 108 EID50 of P22 H5N2 LPAI virus.  Two sets 
of 9 chickens, one group previously exposed to IBDV at 2 days of age and a second group 
non-IBDV infected, were divided into groups of 3. Three chickens from each set were 
sacrificed at 3 dpi, 5 dpi and 7 dpi. Tissue samples and blood were collected from each 
individual. ELISA tests (Synbiotics®) were conducted for each sample. In addition to ELISA 
test HI test was carried out also for AI. 






Antibodies against AIV 




Elisa Elisa Elisa HI Elisa HI Elisa HI Elisa 
1 N+P22 - - - 
2 N+P22 - - - 




4 N+P22 - - - - 40 208 
5 N+P22 - - - - 40 218 
6 N+P22 - - 
 
- - - - 
 
7 N+P22 - - - - - 40 301 40 2083 
8 N+P22 - - - - - - - 40 703 
9 N+P22 - - - - - 40 1237 
1 IBD+P22 + - - 
2 IBD+P22 + - - 
 
3 IBD+P22 + 
 
- - - - 
4 IBD+P22 + + - - - - 
 
5 IBD+P22 + + - - - -  - 
6 IBD+P22 + + 
 
- - - - - - 
7 IBD+P22 + + + - - - - - - 
8 IBD+P22 + + + - - - - - - 
9 IBD+P22 + + + - - - - - - 
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Table 10. Humoral immune response to P22 H5N2 AIV in normal and IBDV-pre-








IBDV + P22 AIV Ab titer 14 dpi 
A g e  I D  Comment s  H I  ELISA  
3 wks  I 1  Norma l  4 0  2407  
3 wks  I 2  Dead 6 dp i  NA NA 
3 wks  I 3  Dead 7 dp i  NA NA 
3 wks  I 4  Dead 6 dp i  NA NA 
3 wks  I 5  Respiratory distress 6-7 dpi. Recovered 8 dpi. 2 0  1567  
3 wks  I 6  Dead 6 dp i  NA NA 
1 wk I 7  Severe respiratory distress. Sacrificed 7 d p i  NA NA 
1 wk I 8  Norma l  < 1 0  0  
1 wk I 9  Norma l  2 0  6 5 9  
P22 AIV  
3 wks  I10 Norma l  1 6 0  4111  
3 wks  I11 Norma l  4 0  4946  
3 wks  I12 Norma l  4 0  3501  
1 wk I13 Norma l  8 0  1671  
1 wk I14 Norma l  2 0  6 8 1  
1 wk I15 Norma l  2 0  2705  
 1 
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5.4.4 Previous IBDV exposure leads to exacerbated signs of disease after 
infection with LPAI.  
Surprisingly, the levels of P22 virus replication in the two groups were similar 
despite our initial observation showing exacerbated signs of disease in the IBDV-pre-
exposed group. IBDV-pre-exposed chickens were lethargic and depressed upon 
infection with the P22 virus.  Four out of 6 IBDV-pre-exposed chickens inoculated 
with the P22 virus (results of two independent studies) showed labored breathing, and 
died between 6 and 7 dpi (Table 10). When examining macroscopically various 
organs of infected birds, lesions with different degrees of severity were observed. In 
the respiratory tract, lesions compatible with pneumonia were evident, although these 
lesions were considerably more severe in IBDV-pre-exposed chickens.  A constant 
finding was severe air sacculitis and occasional presentation of petechial hemorraghes 
in the thymus only in IBDV-pre-exposed-P22 infected chickens.  Histological lesions 
found in lungs after P22 AI virus infection were also more severe in IBDV-pre-
exposed birds compared to naïve chickens (Chapter 4).  These observations indicate 
that host factors or the host’s immune status might play a role in the severity of 
lesions found in the respiratory tract of IBDV-pre-exposed-P22 infected chickens.  
 
5.4.5 Altered host responses as correlates of disease outcome to LPAI P22 virus 
infection 
In order to better understand the effect of IBDV-mediated immunosuppression 
on LPAI infection, global gene expression analysis was performed using an avian 
cDNA microarray on lung tissues from normal and IBDV-pre-exposed chickens.  
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Although our gene expression study included detailed comparative analysis of host 
responses between normal and IBDV-pre-exposed chickens infected with the WT 
H5N2 and the P22 virus, only results with the P22 virus are shown in this chapter.  
IBDV-pre-exposed or normal chickens were infected with the P22 virus at 3 weeks of 
age. At 3 dpi, RNA samples from lungs were prepared as previously described. 
Following AI infection, the avian intestinal IEL cDNA microarray (AVIELA) 
elements that were up- or down-regulated more than 2-fold (p<0.05) in each infection 
group compared to non-infected chickens were analyzed using the Volcano plot.  
Following P22 virus infection in normal chickens, we identified 384 transcripts that 
were significantly changed in the lungs (p<0.05) (201 increased, 183 decreased). In 
IBDV-pre-exposed chickens, infection with P22 virus resulted in significant changes 
in 382 transcripts in the lungs (236 increased, 146 decreased).  To identify elements, 
which are commonly altered in both P22 and IBDV-P22, infection groups, Veen 
Diagram analysis were applied. There were 148 up-regulated elements and 107 down-
regulated elements that were shared between the P22 and IBDV-P22 groups (Figure 
10). 
 
The majority of commonly induced genes were related to the innate immune 
response including interleukins and IL receptors (IL-16, IL-18, IL2RG, IL-7R, IL-12, 
and IL-8).  These genes were induced in both P22 and IBDV-P22 groups (Appendix 
I).  Commonly down-regulated genes in both infection groups were related to various 
other cellular functions (Appendix II). To identify genes, which are differentially 
modulated, the array data of the IBDV-P22 group was compared to those of the P22  
 







Figure 10. Host elements commonly and differentially regulated in chicken lungs 
following P22 and IBD-P22 virus infections. Veen Diagram analysis, A) 148 
elements were commonly up-regulated and B) 107 elements were commonly down-
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group using the Volcano plot method.  The genes that were altered more than 1.5-fold 
(p<0.1 with false discovery rate) were selected. Out of 35 genes, 14 immune genes 
were selected due to their differential expression in the IBDV-P22 infection group 
(Table 11). Real time RT-PCR was used to validate 7 of these genes (Fig 11).  Our 
analysis revealed that the pro-inflammatory cytokine CCL4 (MIP-1β) was induced in 
both groups; however, it was induced 1.6- fold higher in the IBDV-P22 group (Table 
11 and Fig 11). Since CCL4 release is involved in the recruitment of different 
leucocyte populations to the site of inflammation acting preferentially on 
mononuclear cells (Kaufmann et al., 2001; Kobasa et al., 2004; Wareing et al., 2004), 
this may explain the higher amount of cell infiltration of inflammatory cells and 
severe lesions observed in the lungs of chickens in the IBDV-P22 group. It has been 
previously shown that a strong inflammatory response is associated with the 
pathogenicity  of influenza viruses in mammals  (Cheung et al., 2002; Szretter et al., 
2007).     
 
In our study we also found up regulation of the B2M and the TAP genes, with 
a relatively higher increase in the IBDV-P22 group than in the P22 group (Table 11 
and Fig 11). These genes are related to the processing and presentation of antigen 
peptides in the context of the Major Histocompatibility Complex (MHC) Class I 
molecules. An efficient presentation of antigenic peptides to T lymphocytes in 
chickens depends in part on their transport to the cell surface.  An effective and 
functional MHC class I/B2M peptide complex in equilibrium with the transported 
 





Table 11. Differentially expressed genes (>1.5 fold with p<0.1 FDR) in IBDV-pre-exposed-P22 compared with P22- 
infected chicken lungs  
 
Fold change  
Gene symbol and description 
 
GenBank  
Accession  ID 
 




CD3D (CD3d molecule, delta) NM_205512 T cell development 1.5 1.8 2.7 3.2 1.5~2.1b 
LOC693257 (NK-lysin) NM_001044680 Immune response 1.56 3 1.92 
B2M (Beta-2-microglobulin) NM_001001750 MHC I antigen processing 
1.5 2.6 
1.73 
TAP (Transporter associated with antigen 
processing) XM_425302 




CREB3 (cAMP responsive elements binding 
protein 3) XM_424990 Virus reactivation 
1.2 2 
1.66 
TNFSF10 (TRAIL) (TNF (ligand) superfamily 
member 10) NM_204379 Apoptosis 
0.35 0.58 
1.65 
CCL4 (CC chemokine ligand 4) (MIP1 ) NM_001030360 Inflammation 1.8 2.9 1.61 
ITGAV (Integrin, alpha V) NM_205439 Inflammation 0.57 0.92 1.61 
RAC2 (ras-related C3 botulinum toxin 
substrate 2) XM_001237031 IFN alpha induction 
1.25 2 
1.6 
IFI35 (Interferon-induced protein 35) XM_418132 IFN signaling 0.6 0.95 1.58 
GSN (Gelsolin) NM_204934 Inflammation 0.9 0.6 0.66 
IGJ (Immunoglobulin J polypeptide, linker 
protein) NM_204263 




BLNK (B-cell linker) NM_204908 B cell development 3.2 2 0.62 
MCL1 (Myeloid cell leukemia sequence 1) XM_001233734 Apoptosis 3.4 1.8 0.53 
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Figure 11. Relative Quantitative Real Time RT-PCR. Calibrator Normalized Relative 
Quantification (software-based) by Real Time RT-PCR of selected gene products differentially 
expressed in the lung of P22 H5N2 infected chickens.  Total RNA was prepared from lungs of 
P22 H5N2 normal and IBDV-pre-exposed chickens 3 dpi. Fold changes were calculated based on 
the difference in ct values for a particular gene in uninfected (target calibrator) and infected 
(target unknown) lung, which were normalized against GAPDH (Glyceraldehide-3-phosphate-
dehydrogenase) levels (reference). Results are expressed as the target/reference ratio of each 
sample divided by the target/reference ratio of a calibrator. The figure shows normalized ratio of 
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associated with antigen processing (TAP) is needed in order to present efficiently 
peptides derived from the pathogen by the MHC I molecules to the T cells (Kaufman, 
2000; MacDonald, 2007; Riegert et al., 1996). Our results suggest that an increased level 
of expression of these genes in the IBDV-P22 group is perhaps a direct consequence of 
inefficient or altered antigen processing and/or presentation, which results in 
exacerbation of the clinical and pathological signs observed in this group. 
 
We also observed a higher induction of NK-lysin in the IBDV-P22 group (Table 
11 and Fig 11) that could be associated to an increased cytotoxic T cell response. It has 
been shown that NK-lysin is expressed predominantly by CD8+ T and NK lymphocytes 
(Hong et al., 2006; Ruysschaert et al., 1998). CD8+ cytotoxic T lymphocytes play a 
major role in the defense against viral infections (Stenger et al., 1998). In particular, 
populations of cytotoxic T cells have been detected in the lung of mice infected with 
influenza (Ennis et al., 1978; Mozdzanowska et al., 2000). Although the exact role for 
NK-lysin has not been determined in influenza virus associated pneumonia, the enhanced 
level of NK-lysin in the lung may reflect the increased infiltration of inflammatory and 
increased infiltration of inflammatory and T-cell activity seen during acute inflammation 
and pneumonia. 
 
IFN pathway genes were differentially regulated in the two groups, with higher 
induction in the IBDV-P22 group.  These genes included the IFN-induced 35 kDa protein 
and CD3d (Table 11 and Fig 11), which have been previously shown to be differentially 
expressed in studies with a H9 influenza virus (Degen et al., 2006). Chicken CD3d 
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protein shares homology with mammalian CD3γ and CD3δ (Hu et al., 2007). CD3d is 
essential for T cell development and along with the other members of the TCR-CD3 
complex contributes to T-lymphocyte activation after the initial recognition steps. It can 
be speculated that a defective humoral response in birds leads to an exacerbation in the 
release of these cytokines to compensate for important missing signals or responses.  This 
latter argument is in agreement with the up-regulation of genes related to the B cell 
development in the P22 group and a defective response (or down-regulation) in the 
IBDV-P22 group.  Genes involved in IgG and IgA assembly and secretion, including 
BLNK and IgJ (Immunoglobulin J polypeptide, linker protein), were up-regulated in the 
P22 group; however, they were comparatively down-regulated in the IBDV-P22 group 
(Table 11).  These observations could explain the poor antibody response seen against the 
P22 virus in the IBDV-exposed chickens.  As mentioned above, such effect carries 
important implications when considering vaccination against LPAI as overall herd 
immunity is crucial to properly prevent AI infection and spread. Chickens that have been 
previously exposed to IBDV may not respond to the vaccine therefore herd immunity 
may be less than optimal and/or unsatisfactory.  It is also important in the context of 
IBDV vaccination efforts as some of these vaccines have been shown to affect bursa 
morphology and cause immunosuppression (Rautenschlein et al., 2007;  Rosenberger, 
1989; Saif, 1991; Withers et al., 2005). 
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5.5 Discussion 
The emergence of AI viruses with increased pathogenicity that are capable of infecting a 
wide range of land-based birds emphasizes the need to better elucidate the molecular 
mechanisms that modulate AI infections in bird species.  Virulence is the result of a complex 
interaction between the host and the pathogen and plays a major role in host adaptation. In order 
to better understand the fundamental mechanisms involved in host response to AI virus, we used 
a LPAI virus, which showed enhanced virulence upon serial lung passages in a IBDV-pre-
exposed host. In our original hypothesis, we speculated that immunocompromissed chickens 
might provide an environment where a LPAI H5N2 virus could change to a HPAI virus.  After 
22 lung passages (P22) in the exposed host, we obtained a virus with increased virulence but it 
was not a HPAI virus.  Sequencing and in vivo studies revealed that the P22 virus was more 
virulent than the WT in birds but still maintained all the features of a LPAI virus. Our results 
provide some insights on the role that the status of host immunity plays in viral pathogenicity, 
but the current findings also suggest that the host-pathogen interactions during AI infection are 
very complex.  
 
IBDV is an economically important disease that affects poultry worldwide and causes 
severe immunosupression, weakening particularly humoral responses (Rautenschlein et al., 2007; 
Rautenschlein et al., 2003). Because IBDV infection primarily impairs the bursa suppressing 
host humoral antibody response, this experimental system was used to evaluate the effect of 
immunosuppression on influenza infection with a chicken-adapted LPAI H5N2 virus.  The 
results of our study suggest that IBDV-pre-exposure favors the replication of the P22 H5N2 virus 
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and enhances its virulence. Virus titers of P22 H5N2 found in tracheal swabs and tissues (mainly 
in lung) (Figure 8) were elevated compared to the WT virus.  Isolation of AI virus from organs 
other than the respiratory and gastrointestinal tracts is considered a rare event when animals are 
infected with LPAI. Nevertheless, in this study we showed that the P22 H5N2 virus acquired 
increased tissue tropism, caused severe lesions in lungs and was able to produce severe clinical 
respiratory symptoms in IBDV-pre-exposed chickens. The potential impact of this occurring in 
the field could be indeed devastating considering the possibility of AI infection in a large number 
of exposed, susceptible birds in which multiple “passages” can occur in a very short period of 
time. This type of scenario could easily contribute to expanding the host range of LPAI viruses 
and the generation of a new AI strain with novel phenotypes. 
 
Despite many clinical and pathological reports of AI infections, our understanding of 
disease mechanisms and the nature of host factors influencing the viral virulence and/or lung 
pathogenicity are still unknown. Our study was focused on identifying the nature of immune-
related factors that are involved in increased viral pathogenicity in P22 virus-infected chickens. 
Using newly developed tissue-specific AVIELA microarray, this study provides a new 
opportunity to assess mucosal responses to AI virus since this array contains 10,000 EST, which 
were derived from the chicken gut lymphocytes. Because the complete genome sequences of 
chickens have been deciphered (Consortium, 2004; Wallis et al., 2004), high-throughput gene 
expression analysis provides new avenues to investigate global expression of genes controlling 
local immune response to complex pathogens like AI virus. The results of our study indicate the 
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complex interactions between the host and the virus that are evident when analyzing respiratory 
tract lesions and gene expression profiles.   
 
 Recent studies in the mammalian systems clearly indicate important roles that cytokines 
and chemokines play in host innate response to AI and the resulting immunopathology following 
infection with HPAI viruses. Experimental evidence indicates strong association between 
increased cytokine production and enhanced immunopathology following infection with 
influenza viruses (Cheung et al., 2002). It has been previously shown that pro-inflammatory 
cytokines such as CCL4/MIP-1β are up-regulated after in vitro infection with influenza A virus 
(La Gruta et al., 2007). CCL4/MIP-1β expression in particular has been induced after influenza 
virus infection of human monocytes, macrophages, or bronchiolar epithelial cells in vitro 
(Wareign, 2004). Our study shows that P22 virus induces up-regulation of CCL4/MIP-1β in vivo 
and that the level of this cytokine is further up-regulated in IBDV-P22 infected chickens. The up-
regulation of pro-inflammatory cytokines such as CCL4/MIP-1β could indeed be related to the 
increased pathogenicity in lungs observed in this study. CCL4/MIP-1β is also involved in 
inducing the recruitment of different leukocyte populations to the site of inflammation and acts 
preferentially on mononuclear cells (Kaufmann et al., 2001; Kobasa et al., 2004; Wareing et al., 
2004). In this regard, our studies are consistent with this notion since a large amount of 
inflammatory cells was observed in the lung of P22 H5N2 AI virus-infected chickens.  The up-
regulation of CCL4/MIP-1β may also explain the higher infiltration observed in lungs infected 
with the P22 H5N2 virus in the IBDV-pre-exposed group than in the normal chickens. Higher 
infiltration will in turn result in exacerbated local inflammatory responses resulting in more 
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severe disease, as it has been associated with HPAI H5N1 infections (Cheung et al., 2002; La 
Gruta et al., 2007).  
 
Although we concentrated in this report only on differentially expressed genes between 
the P22 and IBDV-P22 infected chickens, we found that many immune related genes including 
interleukins and IL receptors (IL-18, IL-16, IL-12, IL-2RG, IL-7R) were commonly up-regulated 
after P22 infection in both normal and IBDV-infected chickens. In particular, increased induction 
of transcription of IL-16 and IL-18 has been associated to avian influenza exposure (Keeler et 
al., 2007). This may be how the pro-inflammatory role of cytokines differentially expressed after 
P22 AI virus infection could be related with increased severity of lesions and respiratory signs. 
Even though pro-inflammatory cytokines will favor the development of antiviral immunity, an 
exacerbated response may lead to harmful tissue damage (Julkunen et al., 2000).   
 
In contrast to a large amount of gene expression studies done in mammalian models, the 
availability of global gene-expression profiles associated with LPAI viruses is limited in birds.   
Taken together, our findings demonstrate different types of immune responses induced by the 
WT and P22 viruses. Viral titers in the respiratory tract did not correlate with pathological 
lesions and clinical respiratory signs. However, our studies showed that the host’s immune status 
clearly played a role in determining the outcome of humoral response and clinical outcome of AI 
virus infection in chickens following infection with WT and P22 influenza viruses.  We must 
note that we have used a very complex system with an outbred chicken population and a viral 
immunosuppressive agent to induce selective immunosuppression of humoral immune response 
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in chickens.  However, exposure to a LPAI strain in normal and IBDV-pre-exposed chickens 
resulted in differential and consistent different responses that we could easily observe at the 
macro and molecular levels.  Further in vivo studies to examine the role of differentially up-
regulated genes in viral pathogenicity will facilitate the development of logical control strategy 
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Chapter 6:  Conclusions and future prospects 
 
6.1 Conclusions 
Influenza A viruses exhibit varying degrees of host adaptation, which affects infectivity 
and transmissibility. In order to study the role of host factors involved in these processes, we 
studied the effect of IBDV-pre-exposure, a condition very likely to happen in nature, on the 
susceptibility and pathogenesis of a mallard H5N2 LPAI virus in chickens.  
 
Normal chickens infected with 5 x 106 EID50 of the WT virus showed no virus shedding 
from either the trachea or the cloaca or replication in the lungs at 3 dpi.  In contrast, the same 
dose of P22 virus produced an average of approximately 6 log10 EID50 of virus, a ~1 million fold 
improvement compared to the WT virus.  The results are also consistent when CID50 were 
calculated for both viruses, indicating that serial passages in IBDV-pre-exposed chickens of a 
mallard LPAI virus can indeed select for a strain better adapted to chicken.  
 
This study supports the role of host immune status in the adaptation of avian influenza 
viruses. The adaptation did not favor transmission, however the virus gained increased 
pathogenicity. Isolation of virus from serum samples and other organs apart from the respiratory 
and digestive tract are remarkable for a LPAI virus. Macroscopic and microscopic findings 
demonstrated increased severity in lesions caused by the H5N2 P22 adapted virus in both normal 
and IBDV-pre-exposed chickens when compared to the WT virus. Thus our results suggest that 
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the adaptation of a mallard virus in IBDV-pre-exposed chickens could potentially lead to the 
emergence of influenza strains that can cause clinical disease in chickens and infect other species 
with increased replication efficiency.  
 
Complete sequence analysis indicated amino acid changes occurring mainly in the 
surface glycoprotein HA. However changes were also found in PB2, PB1, NP, NA, NS and M. 
Thus multiple different amino acid mutations seem to be associated with virulence in chickens. 
 
Global gene expression analysis indicated that important immune related genes were 
differentially regulated in lung after P22 H5N2 virus infection. It also showed that in agreement 
with clinical signs, macroscopic and microscopic findings, the P22 virus behaves as a respiratory 
pathogen in chickens.  Apparently, there was no evident difference in gene regulation when 
samples from intestinal tissue of infected chicken were evaluated. This demonstrates that 
different host-pathogen interactions mediate avian influenza pathogenesis and disease outcome. 
 
Poultry production is rapidly increasing worldwide, although this increase is not 
necessarily accompanied by improvements in biosecurity or quality of poultry farming and this 
situation becomes critical, particularly in developing countries. In this scenario the potential 
impact of a situation like this occurring in the field is highlighted. A large population of 
susceptible birds could potentially support a large number of passages in a very short period of 
time, generating new AI strains with different phenotypes that could contribute to expand the 
host range of LPAI viruses with unpredictable consequences. 
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6.2 Future prospects and perspectives 
The following studies are needed:  
1) Use reverse genetics system for influenza virus to map specific amino acid residues 
involved in the molecular changes and disease production after 22 passages of the AI virus in 
IBDV-pre-exposed chickens.  
 
2) Identify specific cell populations participating in the inflammatory response in the 
respiratory tract of chickens and determine its role in the pathogenicity of AIV. Clarify 
mechanisms involved in the virulence of avian influenza virus particularly of the H5 subtype is 
important due to its potential to generate HPAI virus and its threat for human health. 
 
Our studies highlight the complexities of influenza infections as they occur in the field:  
IBDV infections remain a worldwide problem in commercial poultry. Vaccination strategies 
against IBDV should be reconsidered as a result of the potential down side effects for increase 
susceptibility to other pathogens. Vaccination strategies against influenza should consider the 
overall health status of the flock and previous exposure or vaccination against other pathogens 
particularly immunossupressive agents. 
 
Based on host molecular responses found in this study and having the ability to detect 
differences in the chemokine and cytokine response to AIV in chickens, we are now able to 
compare and contrast at the transcriptional level the immune responses to different subtypes of 
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AI in chickens and other avian species. Further in vivo studies to examine the role of 
differentially up-regulated genes in viral pathogenicity will facilitate the development of logical 
control strategies against avian influenza infection. 
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Appendix I. The AVIELA genes commonly up-regulated in chicken lung following P22 and IBDV-P22 infections 
 Fold changes    
Clone ID P22 IBD-P22 Gene symbol 
GenBank 
Accession ID Gene description 
18Jul01_J02_1GAL85_033 11.63 6.803 AVD CD729634 mature avidin 
18Jul01_O16_1GAL85_074 7.655 7.877 LOC430511 CD729703 similar to MGC80493 protein 
18Jul01_C18_1GAL85_092 6.613 7.433 LOC427453 CD729705 similar to RIKEN cDNA 5133401N09 
16May01_D24_1GAL55_094 6.52 6.036 LOC420559 CD738021 similar to KIAA2005 protein 
14Feb01_D20_1GAL25_026 5.642 3.92 CD83 CD740590 CD83 molecule 
20Mar01_N12_1GAL32_099 5.279 4.554 c-ets-1 CD733068 c-ets-1 oncogene 
14Feb01_B24_1GAL25_083 4.802 3.467 SURF1 CD740580 surfeit 1 
28Jan01_D08_1GAL2_026 4.706 4.619 LOC421921 CD735098 similar to LOC129607 protein 
24Dec00_F16_1GAL22_056 4.528 4.765 LOC768447 CD740058 similar to immunoglobulin-like receptor CHIR-B4 
2Feb01_O14_1GAL23_031 4.515 2.262 LOC396429 CD740333 min alpha-trop 
20Mar01_A12_1GAL32_084 4.434 3.672 LOC417472 CD733118 similar to Myotubularin related protein 4 
14Feb01_K09_1GAL25_046 4.013 4.606 IGM CD740539 Mu immunoglobulin heavy chain C region 
22Mar01_D17_1GAL50_077 3.989 2.65 IGJ CD733638 
immunoglobulin J polypeptide, linker 
protein for immunoglobulin alpha and 
mu polypeptides 
22Mar01_I21_1GAL50_040 3.95 3.333 SLA CD733715 Src-like-adaptor 
19Mar01_B14_1GAL45_021 3.923 3.352 LCP1 CD737041 lymphocyte cytosolic protein 1 (L-plastin) 
21Aug01_D04_1GAL69_060 3.865 3.211 LOC418295 CD729503 Complement component 1, r subcomponent 
20Jul01_I11_1GAL57_072 3.801 3.496 LOC424357 CD738207 Glutaredoxin 2 
19Jan01_L18_1GAL6_094 3.793 5.188 PCMTD1 CF074910 protein-L-isoaspartate(D-aspartate)O-ethyltransferase domain containing 1 
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27Jan01_G14_1GAL1_027 3.763 2.967 LAPTM4A CD734951 lysosomal-associated protein transmembrane 4 alpha 
20Apr01_O20_1GAL31_042 3.725 3.066 IL18 CD732584 interleukin 18 
14Feb01_H06_1GAL25_093 3.689 3.366 LOC416431 CD740536 similar to ubiquitin specific protease 42 
2Feb01_O12_1GAL23_095 3.653 2.469 LOC422903 CD740332 Hypothetical LOC422903 
14Feb01_C02_1GAL25_025 3.51 2.501 PFKP CD740581 phosphofructokinase, platelet 
20Jul01_K18_1GAL57_096 3.485 3.196 ITGA4 CD738169 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 
20Jul01_I15_1GAL57_040 3.482 2.89 CD8A CD738220 CD8a molecule 
21Aug01_B12_1GAL69_084 3.474 2.305 SCYL2 CD729537 SCY1-like 2 (S. cerevisiae) 
27Jul01_L09_1GAL56_058 3.406 2.729 RCJMB04_18k24 CD734860 similar to Arfaptin 1 (ADP-ribosylation factor interacting protein 1) 
7Mar01_O24_1GAL51_102 3.303 4.117 P20K CD734452 quiescence-specific protein 
3Jul01_H15_1GAL91_048 3.246 2.824 RBMS1 CD738530 RNA binding motif, single stranded interacting protein 1 
18Aug01_P16_1GAL96_074 3.243 3.986 LOC421921 CD739412 similar to LOC129607 protein 
21Aug01_B11_1GAL69_068 3.234 2.455 VPS4B CD729535 vacuolar protein sorting 4 homolog B (S. cerevisiae) 
7Jan01_J01_1GAL10_006 3.206 2.681 APOA1 CD730554 apolipoprotein A-I 
28Jan01_C17_1GAL2_073 3.204 3.52 LOC416706 CD735088 similar to mitochondrial ribosomal protein S5 
20Apr01_O21_1GAL31_058 3.183 2.826 M6PR CD732585 mannose-6-phosphate receptor (cation dependent) 
27Jul01_B11_1GAL56_069 3.176 2.008 BLNK CD734780 B-cell linker 
4Feb01_C01_1GAL28_009 3.111 2.868 IGLV CD726893 Ig light chain variable region 
2Feb01_F03_1GAL23_036 3.064 2.963 RASSF5 CD740323 Ras association (RalGDS/AF-6) domain family 5 
13Jul01_K21_1GAL89_048 3.064 2.613 STK17B CD730147 serine/threonine kinase 17b 
pat.pk0062.b10.f 3.04 2.326 LOC770612 XM_001233949 hypothetical protein LOC770612 
19Mar01_B12_1GAL45_085 3.023 2.667 CEP192 CD737039 centrosomal protein 192kDa 
pmp1c.pk006.o10 3.002 3.458 NOS2A NM_204961 nitric oxide synthase 2A  (NOS2A) 
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19Mar01_C24_1GAL45_092 2.989 2.656 CCNG1 CD737084 cyclin G1 
27Jan01_P13_1GAL1_016 2.986 3.449 COPG CD734909 coatomer protein complex, subunit gamma 
19Mar01_D02_1GAL45_029 2.955 2.637 GLUD1 CD737087 glutamate dehydrogenase 1 
11Dec00_L20_1GAL18_041 2.892 3.05 BTG1 CD733882 B-cell translocation gene 1, anti-proliferative 
21Jul01_M06_1GAL68_098 2.89 2.108 TRIO CD729389 triple functional domain (PTPRF interacting) 
27Apr01_E13_1GAL52_006 2.848 3.332 RCJMB04_22p10 CD734510 Sal-like 4 (Drosophila) 
18Jul01_E02_1GAL85_022 2.821 2.343 CD300L-B1 CD729711 CD300 antigen-like family member 
14Jun01_M24_1GAL42_099 2.798 2.046 PIK3AP1 CD736671 phosphoinositide-3-kinase adaptor protein 1 
18Jul01_F21_1GAL85_039 2.792 2.381 WDR3 CD729631 WD repeat domain 3 
6Jul01_N11_1GAL84_084 2.784 3.259 ADAM28 CD729273 ADAM metallopeptidase domain 28 
7May01_A05_1GAL38_069 2.776 2.843 PHGDHL1 CD731464 phosphoglycerate dehydrogenase like 1 
3Jul01_A24_1GAL91_085 2.763 2.158 LOC770109 CD738676 similar to Cathepsin H 
3Jul01_G05_1GAL91_079 2.761 3.016 ISG12-2 CD738578 putative ISG12-2 protein 
30May01_H06_1GAL62_096 2.752 2.013 LOC421949 CD727489 similar to hypothetical protein DKFZp566A1524 
11May01_K06_1GAL33_101 2.734 3.547 LDHA CD733412 lactate dehydrogenase A 
20Jul01_E22_1GAL57_054 2.734 2.457 RPL5 CD738178 ribosomal protein L5 
22Dec00_K09_1GAL21_048 2.719 2.611 IL16 CD739959 interleukin 16 (lymphocyte chemoattractant factor) 
3Jul01_G06_1GAL91_095 2.71 3.678 SSU72 CD738579 SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae) 
19Jan01_P23_1GAL6_080 2.702 2.442 JMJD4 CD731949 jumonji domain containing 4 
24Dec00_E04_1GAL22_055 2.695 3.057 MAN2C1 CD740160 mannosidase, alpha, class 2C, member 1 
10Mar01_M20_1GAL46_034 2.635 3.365 LOC417534 CD737292 similar to chemokine ah221 
pat.pk0050.a12.f 2.624 2.382 LOC420129 XM_418246.2 similar to interferon, gamma-inducible protein 30  (LOC420129) 
14Feb01_K15_1GAL25_046 2.616 2.247 RBP2 CD740542 retinol binding protein 2, cellular 
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3Feb01_D09_1GAL27_042 2.606 2.271 ZYX CD740609 zyxin 
TGF-beta 4 2.588 3.894 LEFTY2 NM_204764 left-right determination factor 2 
27Apr01_E15_1GAL52_038 2.581 2.855 LOC416564 CD734513 similar to Rho GTPase activating protein 17 
29Jun01_C04_1GAL86_061 2.57 2.499 TBC1D24 CD731852 TBC1 domain family, member 24 
29Jun01_F15_1GAL86_040 2.559 2.86 CD74 CD731815 
CD74 antigen (invariant polypeptide of 
major histocompatibility complex, class 
II antigen-associated) 
31July01_K06_1GAL75_096 2.55 2.916 RAB8A CD736310 RAB8A, member RAS oncogene family 
28Jan01_K22_1GAL2_061 2.532 3.096 LOC425977 CD735007 similar to papillary renal cell carcinoma translocation-associated gene product 
18Aug01_B16_1GAL96_052 2.509 2.276 CXCR4 CD739451 chemokine (C-X-C motif) receptor 4 
11Dec00_A11_1GAL18_069 2.506 2.313 LOC419542 CD733765 similar to AT rich interactive domain 1A 
22Mar01_L20_1GAL50_041 2.491 3.146 TAP1 CD733712 transporter associated with antigen processing 1 
pat.pk0060.h1.f 2.487 2.102 LOC396216 NM_205279 mature cMGF  (LOC396216) 
pmp1c.pk005.g20 2.478 2.625 NCF1 NM_001030709 neutrophil cytosolic factor 1  (NCF1) 
20Jul01_M23_1GAL57_082 2.469 3.421 LOC424360 CD738054 Regulator of G-protein signalling 1 
20Jul01_F04_1GAL57_055 2.464 2.29 SLC43A2 CD738185 solute carrier family 43, member 2 
11Dec00_E07_1GAL18_006 2.443 2.6 LOC416147 CD733803 
similar to Zinc finger protein 147 
(Tripartite motif protein 25) (Estrogen 
responsive finger protein) (Efp) 
11May01_D05_1GAL33_078 2.44 2.961 LOC427623 CD733399 similar to beta-2 adrenergic receptor 
25Mar01_L10_1GAL44_073 2.385 2.523 LRPPRC CD736931 leucine-rich PPR-motif containing 
6Jul01_H13_1GAL84_016 2.382 2.518 LOC768766 CD729262 similar to macrophage hemoglobin scavenger receptor CD163 
2Feb01_D21_1GAL23_042 2.374 2.953 LOC424105 CD740291 similar to inducible T-cell co-stimulator 
3Jul01_H17_1GAL91_080 2.365 3.114 LOC422551 CD738531 Ectonucleotide pyrophosphatase/phosphodiesterase 6 
pat.pk0050.d12.f 2.341 2.671 IL2RG NM_204527 interleukin 2 receptor, gamma  (IL2RG) 
8Dec00_K22_1GAL17_073 2.337 2.118 RCJMB04_1f23 CD733436 similar to cathepsin S preproprotein 
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3Jul01_F10_1GAL91_056 2.329 2.699 RHOQ CD738550 ras homolog gene family, member Q 
19May01_J14_1GAL60_034 2.311 2.6 IL7R CD727187 interleukin 7 receptor 
20Jan01_J21_1GAL8_038 2.29 2.148 LOC395976 CD732391 glutathione S-transferases CL2 
3Feb01_B22_1GAL27_050 2.285 2.054 SLC43A2 CD740759 solute carrier family 43, member 2 
21Jun01_B18_1GAL79_086 2.283 2.188 ZYX CD736529 zyxin 
7Mar01_C06_1GAL51_092 2.28 2.806 XPNPEP3 CD734315 X-prolyl aminopeptidase (aminopeptidase P) 3, putative 
NK-lysin 2.274 2.992 LOC693257 NM_001044680 NK-lysin 
22Dec00_D02_1GAL21_029 2.271 2.689 LOC426107 CD739891 similar to T cell receptor delta chain 
29Jun01_D21_1GAL86_046 2.248 2.578 LOC415493 CD731758 Abhydrolase domain containing 2 
3Jul01_F12_1GAL91_088 2.239 2.223 PTPN6 CD738553 protein tyrosine phosphatase, non-receptor type 6 
20Apr01_O23_1GAL31_090 2.237 2.076 RAB14 CD732589 RAB14, member RAS oncogene family 
22Jun01_E12_1GAL80_087 2.212 2.756 TGM4 CD737566 transglutaminase 4 (prostate) 
70.d3.f 2.205 2.748 IL12 NM_213588 Interleukin 12 
21Jun01_D08_1GAL79_030 2.205 2.004 MMP-13 CD736576 matrix metalloproteinase-13 
26Jun01_J17_1GAL83_082 2.203 2.278 LOC415442 CD729085 similar to normal mucosa of esophagus specific 1 
3Feb01_A23_1GAL27_065 2.185 2.283 LOC420796 CD740739 similar to Nuclear transcription factor, X-box binding 1 
29Jun01_L14_1GAL86_042 2.185 2.632 PCOLN3 CD731927 procollagen (type III) N-endopeptidase 
Lymphotactin 2.177 2.354 LOC395914 NM_205046 Lymphotactin 
7May01_K23_1GAL38_089 2.156 3.547 LOC424953 CD731407 similar to eukaryotic translation initiation factor 4 gamma, 1 
29Jun01_D19_1GAL86_012 2.144 2.439 FIP1L1 CD731756 FIP1 like 1 (S. cerevisiae) 
11Dec00_O06_1GAL18_103 2.141 2.477 HK2 CD733943 hexokinase 2 
22Dec00_D17_1GAL21_078 2.115 2.104 IGLV CD739927 Ig light chain variable region 
4Feb01_M22_1GAL28_055 2.113 3.021 LOC419816 CD726858 Hypothetical LOC419816 
7Mar01_O18_1GAL51_102 2.113 2.062 SLC2A2 CD734447 solute carrier family 2 (facilitated glucose transporter), member 2 
IL-8 2.081 2.582 IL8 NM_205498 Interleukin 8 
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20e7-long2 (pMal) 2.061 2.212 IL2RG NM_204527 interleukin 2 receptor, gamma  (IL2RG) 
2Aug01_K04_1GAL71_064 2.056 2.596 DDX47 CD731547 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 
6Jan01_C10_1GAL4_061 2.045 2.018 LOC415442 CD730183 similar to normal mucosa of esophagus specific 1 
11Dec00_F23_1GAL18_072 2.04 2.7 CD44 CD733748 CD44 molecule 
18Jul01_I16_1GAL85_056 2.04 2.388 RAC2 CF074851 
ras-related C3 botulinum toxin substrate 
2 (rho family, small GTP binding protein 
Rac2) 
12c4 2.026 2.149 GM-CSF NM_001007078 Granulocyte-macrophage colony stimulating factor 
8Dec00_G05_1GAL17_079 2.021 2.156 COL4A3BP CD733496 collagen, type IV, alpha 3 binding protein 
22Dec00_E06_1GAL21_087 2.011 2.048 HARS CD739957 histidyl-tRNA synthetase 
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Appendix II. The AVIELA genes commonly down-regulated in chicken lung following P22 and IBDV-P22 infections 
 Fold changes    
Clone ID P22 IBD-P22 Gene symbol 
GenBank 
Accession ID Gene description 
29Jun01_M05_1GAL86_083 0.0963 0.108 LOC419791 CD731941 Hypothetical LOC419791 
24Dec00_G08_1GAL22_030 0.107 0.129 LOC770561 CF075140 Archain 1 
6Jun01_J01_1GAL70_018 0.111 0.12 LOC423942 CD735572 similar to DMBT1 4.7 kb transcript 
11May01_N08_1GAL33_036 0.149 0.196 HBB CD733413 hemoglobin, beta 
24Dec00_I01_1GAL22_008 0.15 0.222 LOC421949 CD740182 similar to hypothetical protein 
DKFZp566A1524 
22Mar01_M13_1GAL50_018 0.169 0.229 LOC420045 CD733580 similar to keratin 17n 
27Apr01_F06_1GAL52_087 0.172 0.199 LOC427380 CD734564 similar to chromosome 9 open reading 
frame 97; PP4189 
24Dec00_E21_1GAL22_038 0.193 0.222 LOC419498 CD740178 similar to guanylin precursor 
24Dec00_C01_1GAL22_012 0.204 0.207 LOC419390 CD740249 similar to enhancer of split related 
protein-7 
15Dec00_K16_1GAL16_073 0.217 0.253 B-G CD733178 V-region-like B-G antigen 
27Mar01_B08_1GAL12_021 0.224 0.241 TSPAN8 CD730930 tetraspanin 8 
24Dec00_D08_1GAL22_029 0.225 0.235 ARF6 CF075142 ADP-ribosylation factor 6 
1Jun01_C07_1GAL64_013 0.246 0.264 LOC415791 CD728040 similar to carbonic anhydrase VII 
30Jun01_L19_1GAL87_026 0.247 0.26 ALDOB CD729850 aldolase B, fructose-bisphosphate 
18Feb01_P24_1GAL43_102 0.256 0.374 TMEM23 CD736793 transmembrane protein 23 
22Mar01_O23_1GAL50_090 0.257 0.26 REV1 CD733717 REV1 homolog (S. cerevisiae) 
25July01_J24_1GAL59_097 0.268 0.299 CDH17 CD738704 cadherin 17, LI cadherin (liver-intestine) 
24Dec00_C04_1GAL22_061 0.268 0.312 DNAJC16 CD740250 DnaJ (Hsp40) homolog, subfamily C, 
member 16 
15Dec00_H06_1GAL16_096 0.286 0.298 LOC768796 CD733233 Hydrolethalus syndrome 1 
24Dec00_A12_1GAL22_085 0.293 0.333 LOC424862 CD740111 similar to prostaglandin transporter 
22Mar01_O17_1GAL50_090 0.295 0.339 VTN CD733706 vitronectin 
22Mar01_K02_1GAL50_032 0.297 0.245 CDKN2A CD733653 cyclin-dependent kinase inhibitor 2A 
(melanoma, p16, inhibits CDK4) 
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pat.pk0038.h8.f 0.308 0.252 ITGA1 NM_205069 integrin, alpha 1  (ITGA1) 
21Jun01_A17_1GAL79_069 0.325 0.441 PAN3 CD736592 PAN3 polyA specific ribonuclease 
subunit homolog (S. cerevisiae) 
19Mar01_A19_1GAL45_003 0.335 0.362 LOC771974 CD737227 similar to Cytochrome P450 4A2 
precursor (CYPIVA2) (Lauric acid 
omega-hydroxylase) (P450-LA-omega 
2) (P450 K-5) (P-450 K-2) 
15Jun01_K02_1GAL65_041 0.342 0.235 UGT1A10 CD728259 UDP glucuronosyltransferase 1 family, 
polypeptide A10 
17July01_N16_1GAL93_067 0.343 0.347 ALDH2 CD739080 aldehyde dehydrogenase 2 family 
(mitochondrial) 
5Jun01_N07_1GAL39_020 0.343 0.441 PHPT1 CD735765 phosphohistidine phosphatase 1 
5Jun01_D12_1GAL39_094 0.349 0.425 GOLPH2 CD735739 golgi phosphoprotein 2 
7May01_C12_1GAL38_093 0.351 0.421 DYRK1A CD731318 dual-specificity tyrosine-(Y)-
phosphorylation regulated kinase 1A 
31July01_N19_1GAL75_019 0.352 0.459 MYH9 CD736318 myosin, heavy chain 9, non-muscle 
7Jun01_B16_1GAL37_054 0.357 0.486 ATAD1 CD735411 ATPase family, AAA domain containing 
1 
27Apr01_F07_1GAL52_007 0.366 0.333 LOC422284 CD734565 similar to Rho-GTPase-activating 
protein 6 (Rho-type GTPase-activating 
protein RhoGAPX-1) 
2Aug01_P01_1GAL71_027 0.372 0.427 SLMAP CD731592 sarcolemma associated protein 
3Jun01_P15_1GAL63_060 0.373 0.455 EPAS1 CD727877 endothelial PAS domain protein 1 
29Jun01_C20_1GAL86_029 0.373 0.274 PGDS CD731744 prostaglandin-D synthase 
10Jun01_M24_1GAL66_099 0.374 0.35 LECT2 CD728934 Leukocyte cell-derived chemotaxin 2 
7May01_M02_1GAL38_035 0.381 0.342 GDPD4 CD731452 glycerophosphodiester 
phosphodiesterase domain containing 4 
19May01_A08_1GAL60_021 0.386 0.482 LOC428569 CD727174 Solute carrier family 3 (cystine, dibasic 
and neutral amino acid transporters, 
activator of cystine, dibasic and neutral 
amino acid transport), member 1 
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20Mar01_K11_1GAL32_080 0.387 0.412 LOC428771 CD733155 similar to aminopeptidase A 
27Mar01_D19_1GAL12_013 0.39 0.455 LOC419988 CD730915 ABI gene family, member 3 
29May01_A04_1GAL53_053 0.395 0.301 ANXA13 CD734717 annexin A13 
15Aug01_J04_1GAL88_056 0.396 0.334 LOC425272 CD729989 similar to This CDS feature is included 
to show the translation of the 
corresponding V_region. Presently 
translation qualifiers on V_region 
features are illegal 
24Dec00_G07_1GAL22_014 0.398 0.418 LOC418569 CD740103 similar to ubiquitin specific protease 9, 
X-linked 
24Dec00_E19_1GAL22_006 0.401 0.419 LOC422224 CD740173 similar to growth and transformation-
dependent protein 
25Mar01_J21_1GAL44_049 0.407 0.458 KPNA2 CD736903 karyopherin alpha 2 (RAG cohort 1, 
importin alpha 1) 
20Mar01_G08_1GAL32_030 0.408 0.405 RCJMB04_17m23 CD733109 similar to hypothetical protein FLJ25467 
20Mar01_M24_1GAL32_098 0.412 0.373 LGALS3 CD733054 lectin, galactoside-binding, soluble, 3 
20Mar01_I13_1GAL32_008 0.412 0.418 RCJMB04_2n20 CD732993 Tumor protein p53 inducible nuclear 
protein 1 
5Jun01_C16_1GAL39_061 0.414 0.407 LOC427838 CD735718 Hypothetical LOC427838 
20Mar01_C10_1GAL32_060 0.416 0.488 MOV10 CD733087 Mov10, Moloney leukemia virus 10, 
homolog (mouse) 
20Mar01_L13_1GAL32_025 0.423 0.491 SUCLG2 CD733001 succinate-CoA ligase, GDP-forming, 
beta subunit 
29Jun01_G03_1GAL86_045 0.426 0.436 STK25 CD731848 serine/threonine kinase 25 (STE20 
homolog, yeast) 
4Jul01_F15_1GAL92_040 0.429 0.369 LOC424751 CD738857 similar to myosin VIIA 
22Dec00_P08_1GAL21_043 0.431 0.407 ULK1 CD740037 unc-51-like kinase 1 (C. elegans) 
26Jun01_N24_1GAL83_100 0.432 0.403 SLC25A6 CD729154 solute carrier family 25 (mitochondrial 
carrier; adenine nucleotide translocator), 
member 6 
pat.pk0032.g5.f 0.437 0.443 IRAK2 NM_001030605 interleukin-1 receptor-associated kinase 
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2  (IRAK2) 
17July01_O12_1GAL93_102 0.443 0.39 ADHFE1 CD739016 alcohol dehydrogenase, iron containing, 
1 
20Mar01_O11_1GAL32_090 0.445 0.414 TNFRSF21 CD732997 tumor necrosis factor receptor 
superfamily, member 21 
7Mar01_N11_1GAL51_083 0.446 0.481 CEP170 CD734397 centrosomal protein 170kDa 
29May01_D15_1GAL53_046 0.447 0.418 LOC429330 CF074994 similar to Mll2 protein 
24Dec00_E22_1GAL22_055 0.447 0.463 PCNA CD740179 proliferating cell nuclear antigen 
12May01_L08_1GAL35_042 0.449 0.441 GPATCH3 CD734263 G patch domain containing 3 
15Dec00_N04_1GAL16_068 0.453 0.3 RBP2 CD733170 retinol binding protein 2, cellular 
11Aug01_A12_1GAL94_083 0.454 0.437 LGALS3 CD739216 lectin, galactoside-binding, soluble, 3 
6Jul01_O22_1GAL84_075 0.458 0.46 LOC777441 CD729298 Hypothetical protein LOC777441 
24Apr01_F22_1GAL41_055 0.459 0.482 LOC427199 CD733296 similar to molybdopterin synthase large 
subunit 
pat.pk0049.h5.f 0.465 0.462 ITM2A NM_001012571 integral membrane protein 2A  (ITM2A) 
30May01_N19_1GAL62_020 0.468 0.438 RW1 CD727660 RW1 protein 
7Mar01_C18_1GAL51_092 0.471 0.495 PSCD4 CD734326 pleckstrin homology, Sec7 and coiled-
coil domains 4 
18Aug01_N12_1GAL96_098 0.474 0.436 FCGBP CD739581 Fc fragment of IgG binding protein 
22Mar01_D21_1GAL50_045 0.475 0.451 IFNAR1 CD733646 interferon (alpha, beta and omega) 
receptor 1 
7May01_N04_1GAL38_068 0.479 0.443 SGPL1 CD731495 sphingosine-1-phosphate lyase 1 
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